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CHAPTER 1 
INTRODUCTION 
            Fluid therapy plays an important role in achieving optimal outcomes 
after surgery and it continues to be one of the most controversial aspects of 
perioperative care
1
. The aims of perioperative fluid administration are to 
avoid dehydration, to maintain an effective circulating volume, and to 
prevent inadequate tissue perfusion during a period when the patient is 
unable to achieve these goals through normal oral fluid intake
2
. Knowledge 
of the effects of different fluids has increased in recent years, and the choice 
of fluid in a variety of clinical situations can now be rationally guided by an 
understanding of the physicochemical and biological properties of the 
various fluids available. However, there are only few useful clinical 
outcome data to guide this decision. Deciding how much fluid to give has 
historically been more controversial than choosing which fluid to give
3
. 
            The data about peri-operative fluid on outcomes, from major surgery 
are contradictory, with some studies reporting fluid restriction to reduce 
length of postoperative ileus and decrease postoperative complications
4
. 
Other investigators report benefits (primarily reduced length of 
postoperative ileus and reduced hospital stay) of individualized, goal-
directed fluid administration
5
.  Data from randomized, clinical trials 
consistently indicate that 1–2 L IV fluid (predominantly crystalloid) 
2 
improves outcomes such as dizziness, nausea and vomiting after minor 
surgery
 
.The lack of procedure-specific evidence based guidelines for peri-
operative fluid management results in large variations of administered fluid 
regimens in daily practice. 
             Adverse outcomes such as nausea, vomiting, thirst, drowsiness, and 
dizziness can create great discomfort in ambulatory patients. Postoperative 
nausea and vomiting (PONV) is a common complication after ambulatory 
surgery. PONV can lead to high levels of patient distress and 
dissatisfaction
6
. It is a limiting factor in the early discharge of ambulatory 
surgery patients and also a leading cause for unanticipated hospital 
admission 
7
. Current approaches for the prevention and treatment of PONV 
remain limited, and >25% of patients continue to experience PONV within 
24 h of surgery
8
 .Among high risk patients, the incidence of PONV is as 
frequent as 80%
9
. Although some advocate prophylactic antiemetic therapy 
for high risk patients, with rescue antiemetic treatment for episodes of 
PONV, the optimal approach remains unclear
10
 .There remains a need to 
develop cost effective, ideally non pharmacologic strategies to decrease the 
incidence of PONV. 
            Intravascular volume deficits may be a factor in PONV and 
perioperative administration of IV fluids may reduce the incidence of 
adverse outcomes in outpatient surgery
11
.  Perioperative administration of a 
3 
sufficient volume of IV fluids to correct this deficit may effectively prevent 
PONV .The combined intraoperative anesthetic and surgical losses that are 
often inadequately replaced, results in hypovolemia with reduced blood flow 
to the gut. Gut ischemia, if  not corrected, is associated with excessive 
release of serotonin. Thus, fluid supplementation reduces the incidence of 
PONV, most probably, by improving the mesenteric perfusion and 
preventing gut ischemia and the resultant serotonin release. However, 
studies of perioperative fluid administration have used  differing 
methodologies and have drawn conflicting conclusions
12 
. Therefore, the 
potential efficacy of IV fluid therapy in reducing PONV remains to be 
convincingly demonstrated. 
           Hence a study was planned to examine the hypothesis that the 
administration of large volume IV fluids to patients undergoing ambulatory 
surgery would reduce the incidence and/or severity of  PONV  and other 
adverse outcomes postoperatively.  
           We propose to test this hypothesis in a common surgery that is 
conducted extensively across the country which would benefit if the patient 
will achieve discharge criteria at the earliest. 
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CHAPTER 2 
AIM OF THE STUDY 
             The aim of this randomized study was to compare the effect of 
Liberal and Restrictive fluid protocol on post-operative nausea vomiting and 
discharge criteria in patients undergoing puerperal sterilization under GA as 
day care surgery. 
Primary Objectives 
1. Incidence and severity of Post-operative nausea and vomiting. 
2. Incidence and severity of Pain. 
Secondary Objectives 
1. Discharge criteria 
2.  Patient well-being as assessed by thirst, headache, dizziness, 
drowsiness and  fatigue 
3. Post-operative Ileus. 
4.  Post-operative Exercise capacity and mobilization. 
 
  
5 
CHAPTER 3 
FLUID PHYSIOLOGY 
FLUID COMPARTMENTS
13,14 
             Water constitutes about 60% of total body weight in the average 
adult, varying with age, gender, and body composition. Adipose tissue 
contains little water compared with other tissues, leading to marked 
variability in total body water (TBW) proportion between lean (75%) and 
obese (45%) individuals and between adult males and females.  TBW is 
divided between anatomic and functional fluid compartments within the 
body, with the major division between intracellular fluid (ICF) and 
extracellular fluid (ECF). The extracellular fluid can be subdivided into the 
following compartments: 
Interstitial fluid (ISF) 
Lymphatic fluid and protein poor fluid occupying cell spaces. 
 Intravascular fluid 
Plasma volume, including a proportion contained within the 
subglycocalyx 
6 
Transcellular fluid 
Includes gastrointestinal (GI) tract fluid, bile, urine, cerebrospinal 
fluid, aqueous humor, joint fluid, and pleural, peritoneal, and pericardial 
fluid.  
Figure 1 :  Distribution of total body water 
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PHYSICOCHEMICAL LAWS GOVERNING FLUID AND 
ELECTROLYTE MOVEMENT 
             The movement of water and solutes is governed by a variety of 
physicochemical and biologic processes. 
Diffusion 
           Diffusion is the process by which solute particles fill the available 
solvent volume by moving from areas of high to low concentration 
according to Fick’s law of diffusion: 
J = − DA(Δc/Δx) 
where J is the net rate of diffusion,   D is the diffusion coefficient, A is the 
cross-sectional area available for diffusion, and Δc/Δx is the concentration 
(chemical) gradient. Diffusion also may be driven by the tendency of 
charged solutes to move down electrical gradients. 
Osmosis  
            If a semi-permeable membrane separates pure water from water in 
which solute is dissolved, water molecules will diffuse across the membrane 
8 
from region of   lower solute concentration into the region of higher solute 
concentration.  
Osmotic pressure in an ideal solution is affected by temperature and 
volume. 
                                               P = nRT/V 
where  P is the osmotic pressure, n is the number of particles, R is the gas 
constant, T  the absolute temperature and V the volume. The total osmotic 
pressure of plasma is approximately 5545 mm Hg. 
Osmolality  
Osmolality may be used to describe solutions containing many 
different types of particles and is the number of osmoles (each containing 
6.023 ×10
23 
of any type of particle present) present in 1 kg of solvent. 
Normal body osmolality is 285 to 290 mOsm/kg. The largest contribution to 
plasma osmolality is made by sodium and its related anions chloride and 
bicarbonate. It can be calculated by: 
Serum osmolality =[ (2 × Na) + (glucose ÷ 18)+ (BUN ÷ 2.8) ] 
9 
where Na is the serum sodium concentration (mEq/L), glucose is the serum 
glucose concentration (mg/dL), BUN is the blood urea nitrogen 
concentration (mg/dL), and the (2 × Na) component reflects both Na and its 
associated anions (predominantly Cl
−
 and HCO3
-
) 
Osmolarity is the number of osmoles of solute per liter of solution 
Tonicity  
Tonicity is important in determining in vivo distribution of fluids 
across a  cell membrane.  
Oncotic Pressure  
Oncotic pressure is the component of total osmotic pressure  due to 
the colloid - that is, large-molecular-weight particles, predominantly 
proteins (albumin, globulins, fibrinogen). Of the total plasma osmotic 
pressure of 5545 mm Hg, 25 to 28 mm Hg is due to plasma oncotic 
pressure.  As the most abundant plasma protein, albumin is responsible for 
65% to 75% of plasma oncotic pressure. 
  
10 
Crystalloid Versus Colloid Intravascular Volume Effects  
Infused crystalloid has been thought to distribute evenly throughout 
the extracellular compartments as a result of capillary filtration, leaving 
approximately one fourth or one fifth of the original volume within the 
circulating blood volume, whereas colloids were presumed to initially 
remain largely within the intravascular volume. 
Crystalloids initially distribute throughout the plasma and the 
subglycocalyceal layer (SGL) volumes. Context sensitivity is responsible for 
the observation that clearance of crystalloid from its central compartment 
(the intravascular volume) is slower under anesthesia than in awake 
subjects
15.
  
The importance of the endothelial glycocalyx is highlighted by 
studies showing that its degradation significantly impairs endothelial barrier 
function
16
. Maintenance of glycocalyx integrity is therefore gaining interest 
as a therapeutic target in perioperative fluid management. 
To rationally prescribe fluid replacement, it is important to identify 
which compartment is depleted: specific losses should be replaced with the 
appropriate fluid. 
11 
CHAPTER  4 
FLUID PHARMOCOLOGY 
In 1861, Thomas Graham classified  substances as crystalloids or 
colloids based on their ability to diffuse through a parchment membrane. 
IV fluids are broadly be classified into colloid and crystalloid 
solutions. They vary in their physical, chemical, and physiological 
properties. 
CRYSTALLOIDS 
Solutions of inorganic ions and organic molecules dissolved in water 
are referred to as crystalloids. The main solute is either glucose or sodium 
chloride  and the solutions may be isotonic, hypotonic, or hypertonic with 
respect to plasma. Potassium, calcium, and lactate may be added to more 
closely replicate the ionic makeup of plasma. Crystalloids with an ionic 
composition close to that of plasma is referred  as “balanced” or 
“physiological.” 
  
12 
ISOTONIC SALINE
17
 
One of the most commonly used crystalloid fluids is 0.9% sodium 
chloride. It has different names, including normal saline, physiologic saline, 
and isotonic saline. 
FEATURES 
Its osmolarity  (308) is slightly higher than that of plasma, although 
the osmolality (285 mOsm/kg) is very similar to that of plasma.     
Infusions of 0.9% NaCL cause interstitial edema more than 
crystalloid fluids
 18
  due to the higher sodium load from 0.9% NaCL, which 
increases the “tonicity” of the interstitial fluid  and promotes sodium 
retention by suppressing the renin-angiotensin-aldosterone axis
19
. Decreases 
in renal perfusion is also observed  as a result of chloride-mediated renal 
vasoconstriction. 
It also leads to an increase in ECF volume, dilutional decrease in 
hematocrit and albumin, increase in Cl− and K+ concentrations, and 
decrease in HCO3
-
. The excess salt and water load may take multiple days 
for even a healthy subject to excrete. 
13 
 Large-volume infusions of 0.9% NaCL produce a metabolic acidosis. 
The saline-induced metabolic acidosis is hyperchloremic acidosis  and is  
caused by the high concentration of chloride in 0.9% saline relative to 
plasma (154 versus 103 mEq/L). 
          The  compelling indications are  
• Situations in which increased plasma Na+ may be beneficial, such 
as in the presence of cerebral edema. 
• Preexisting Na+ or Cl− total body depletion, such as gastric outlet 
obstruction. 
Ringer’s Fluids 
20
 
Sydney Ringer, a British physician  studied the contraction of isolated 
frog hearts and he  introduced the  sodium chloride solution in 1880 which 
contained calcium and potassium to promote cardiac contraction and cell 
viability .This solution is known as Ringer’s injection and is 0.9% NaCL 
with added potassium and ionized calcium. 
Ringer’s Lactate 
In the early 1930’s, an American pediatrician, Alexis Hartmann added 
sodium lactate to Ringer’s solution to provide a buffer for the treatment of 
14 
metabolic acidosis . This solution was initially called as Hartmann’s 
solution, and is now known as Ringer’s lactate solution. The sodium 
concentration in Ringer’s lactate is reduced to compensate for the sodium 
released from sodium lactate, and the chloride concentration is reduced to 
compensate for the negatively-charged lactate molecule; both changes result 
in an electrically neutral salt solution. The reduction in anionic content is 
compensated for by the addition of stable organic anionic buffers such as 
lactate, gluconate, or acetate. The osmolality of balanced solutions (265 
mOsm/kg) is slightly lower than that of  plasma, and they are therefore 
mildly hypotonic. 
After administration, the buffer is metabolized to produce HCO3 − in 
equimolar quantities by entry into the citric acid cycle.  
Ringer’s Acetate 
Because of concerns that large-volume infusions of Ringer’s lactate 
solution could increase plasma lactate levels in patients with impaired 
lactate clearance the lactate buffer was replaced by acetate to create 
Ringer’s acetate solution.  
  
15 
Advantage  and  Disadvantages   
The principal advantage of Ringer’s lactate and Ringer’s acetate over 
isotonic saline is the lack of a significant effect on acid-base balance. 
The principal disadvantage of Ringer’s solutions is the calcium 
content; i.e., the ionized calcium in Ringer’s solutions can bind to the 
citrated anticoagulant in stored RBCs and promote clot formation.  
Concerns that large doses of d-lactate may be associated with 
encephalopathy
21 
and cardiac toxicity in patients with renal failure
22 
have not 
been confirmed in humans. 
Lactated solutions should be avoided in severe liver failure. Acetate is 
metabolized in muscle rather than liver , which makes Ringer’s acetate a 
reasonable alternative to Ringer’s lactate in patients with liver failure.  
DEXTROSE SOLUTIONS 
Dextrose solutions have the following two main indications in the 
perioperative setting. 
Isotonic glucose solution should be prescribed to treat simple 
dehydration and provide water replacement. The hypertonic glucose 
16 
solutions are given to provide glucose as a metabolic substrate in 
hypoglycemia or in combination with insulin therapy. 
Other Balanced Salt Solutions 
Two of the crystalloid (i.e., Normosol and Plasma-Lyte) contain 
magnesium instead of calcium, and contain both acetate and gluconate 
buffers to achieve a pH of 7.4 These fluids are not as popular as isotonic 
saline or Ringer’s lactate, but the absence of calcium makes them suitable as 
diluents for RBC transfusions, and Plasma- Lyte has shown less of a 
tendency to promote interstitial edema when compared with isotonic saline. 
Figure 2  :    Comparison of Crystalloids 
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COLLOIDS 
A colloid is a particulate solution with particles that do not dissolve 
completely. These solutions are also called suspensions. It is a saline 
solution with large solute molecules which  do not pass readily from plasma 
to interstitial fluid. The retained molecules in a colloid  create an osmotic 
force called the colloid osmotic pressure or  oncotic pressure that holds 
water in the vascular compartment. 
VOLUME EFFECTS  
Colloid  is about 3 times more effective in expanding the plasma 
volume than the crystalloid.  Crystalloid fluids reduce the plasma COP 
whereas Colloid fluids can preserve the normal COP ie 20 to 30 mm Hg. 
CLASSIFICATION 
Colloid solutions used in clinical practice are divided into the semi-
synthetic colloids (gelatins, dextrans, and hydroxyethyl starches (HES) and 
the naturally occurring human plasma derivatives (human albumin 
solutions, plasma protein fraction, fresh frozen plasma, and immunoglobulin 
solution).  
18 
The semi-synthetic colloids and the various preparations of plasma 
proteins in solution have a wide distribution of molecular sizes and are 
described as “polydisperse”. Human albumin solution contains more than 
95% albumin with a uniform molecular size and is described as 
“monodisperse.”  
PROPERTIES 
The semi-synthetic colloids are a heterogeneous group of products 
that vary in the magnitude and duration of Plasma Volume Expansion 
(PVE), effects on hemostasis, interaction with endothelial and inflammatory 
cells, adverse drug reactions, and cost. 
The predominant effect of colloid solutions on blood rheology is to 
reduce  blood viscosity by  hemodilution , thus improving blood-flow. The 
higher-Molecular Weight (MW)  dextrans and HES cause an increase in 
plasma viscosity, and the larger dextrans  and gelatins also tend to cause red 
cell aggregation
 23
.  
All of the semi-synthetic colloids affect hemostasis. This occurs 
partly as a result of hemodilution of clotting factors and effects on 
components of the hemostatic mechanism. The gelatins appear to have the 
least effect on hemostasis. HES solutions have varying effects on 
19 
hemostasis that are dependent on the MW of the HES molecule.
24
. The 
dextrans are associated with more significant hemostatic derangements  
Dextran and HES molecules may also have specific anti-
inflammatory effects
25
.  
Anaphylaxis or anaphylactoid events have been described in 
association with all of the semi-synthetic colloids and albumin.  
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CHAPTER 5 
PERI-OPERATIVE  FLUID  MANAGEMENT 
Reduced Fasting Duration – Enhanced Recovery After Surgery 
Guidelines 
These guidelines were developed for patients who undergo elective 
colorectal surgery and in whom a significant delay in gastric emptying is not 
suspected. 
1. Patients should be allowed to eat solid foods until 12 midnight
 
and 
clear liquids until 2 to 3 hours before surgery or until they leave for 
the hospital.
26,27
 
2. Patients should be encouraged to drink a suitable carbohydrate rich 
drink,  upto 800  ml at bedtime the night before surgery and 400 ml 
until 2 to 3 hours
 
 before surgery  or until they leave for the 
hospital.
26,27
 
Studies
28
 have shown that passive regurgitation and pulmonary 
aspiration  occurs  during  anaesthesia when the  gastric volume is more than 
200 ml. Many recent studies have  reported a preoperative mean gastric 
21 
fluid volume in the range of 10 to 30 ml , with 120 ml rarely exceeded in 
spite of intake of clear fluids.
29 
 
The Cochrane review
30 
has recommended that ideally patients should 
come to surgery in a metabolically fed state, rather than starving and ketotic. 
A carbohydrate load given preoperatively may lead to reduced insulin 
resistance, decreased stress response to surgery, earlier return of bowel 
function and shortened length of stay. There is little evidence that 
carbohydrate loading results in improvement of other surgical outcomes
31
 
The current guideline of solid intake of 6 hours is based on the 
estimated physiologic gastric emptying time for healthy patients. An 
ultrasonographic study by Soreide et al.
32
 showed that 4 hours of fasting was 
required to guarantee complete emptying of solid particles after a light 
breakfast.  
In summary, the evidence that favours reducing fasting times appears 
to be sufficient and is supported by numerous Worldwide guidelines. 
Reducing the fasting time to 2 hours for clear fluids and 6 hours for solids 
does not increase the risk of regurgitation or pulmonary complications in 
patients who are otherwise healthy.
33
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APPROACHES TO FLUID MANAGEMENT  
During peri-operative period, the fasting duration and subsequent 
trauma of surgery induces a range of neurohumoral and inflammatory 
changes, termed the stress response which can have a significant impact on 
fluid distribution.  
Fluid requirement is a dynamic situation with great interindividual 
variability. This vary depending on patient factors, including weight and co-
morbidity, and on surgical factors, such as the magnitude and site of 
surgery. Different fluid requirements are have been successfully used during 
the peri-operative period. 
In “low-risk” minor surgery, fluid strategies may influence the 
incidence of relatively minor morbidity such as nausea and vomiting, 
whereas in major surgery the focus is on the potential for fluid 
administration to affect major postoperative morbidity and mortality. 
IV fluid quantities may be given in two main ways :  
1. By estimating the requirements based on patient weight, the phase of 
surgery, and nature of losses to estimate the required dose.  
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2. By direct measurement of an individual’s physiologic variables, and 
administering fluid in sufficient quantities to achieve an improvement 
in these physiologic variables, so-called “Goal-directed therapy”. 
Traditional Fluid Management ( HOLLIDAY SEGAR FORMULA) 
This is based on historical estimates of fluid requirements during 
fasting (e.g., using the “4-2-1” calculation) and during episodes of excess 
loss, such as when body cavities are open or bleeding occurs. In preparing 
for elective surgery, oral clear fluid intake should continue until 2 hours 
preoperatively and longer fasting discouraged. The use of preoperative 
bowel preparation should be restricted to carefully selected cases, and in 
these cases an infusion of 1 to 2 L of balanced crystalloid with K+ 
supplementation should be given in the preoperative period. 
Maintenance Requirements for Water, Sodium and Potassium 
Sufficient water is required to balance gastrointestinal losses of 100–
200 ml/day, insensible losses of 500–1000 ml/day (half of which is 
respiratory and half cutaneous); urinary losses of 1000 ml/day. The 
predicted daily maintenance fluid requirements for healthy, 70-kg adults is 
2500 ml/day of a solution with a [Na+] of 30 mEq/l and a [K+] of 15–20 
mEq/l.  
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Table  1 : HOLLIDAY SEGAR FORMULA 
         Weight (kg)          ml/kg/h                  ml/kg/day 
           1–10               4           100 
          11–20              2             50 
            > 21              1             20 
 
Surgical Fluid Requirements 
 Minimal tissue trauma (ex. herniorrhaphy) :  2-4  ml/kg/hr 
 Moderate tissue trauma (ex. Cholecystectomy ):  4-8 ml/kg/hr 
 Severe tissue trauma (ex. bowel resection) : 10 – 15  ml/kg/hr 
Compensatory Intravascular Volume Expansion 
           Vasodilation caused by anesthetics affects both the venous and 
arterial systems and may reduce cardiac preload and afterload. Cardiac 
output also may be decreased by the negative inotropic effect of anesthetic 
drugs. Therefore, fluid must be administered to expand the blood volume to 
compensate for venodilation. Compensatory Intravascular  Volume  
Expansion (CIVE) with 5 to 7 ml/kg of balanced salt solution must occur 
prior to, or simultaneous with, the onset of anesthesia. 
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Bleeding   
Bleeding leads to direct loss of intravascular volume. Crystalloid 
being used to replace blood loss in a 3:1 ratio to account for crystalloid 
movement into the extravascular compartment
34
 
Insensible losses 
The opening of anatomic compartments leads to evaporative fluid loss 
from mucosal surfaces, although estimating the extent of this loss may be 
difficult. Lamke et al
35
 experimentally evaluated  the insensible perspiration 
and proposed  that it was highly overestimated . The authors calculated that 
baseline evaporation was approximately 0.5 ml/Kg/h in the awake adult and 
that it could increase to 1 mL/Kg/h at the most, during large abdominal 
surgery. 
Inflammation-related redistribution 
Major surgery induces an inflammatory response that favors 
redistribution of fluid from the intravascular to the extracellular 
compartment. 
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A  classic third space   
It was never localized and only “quantified” with one specific method 
using certain conditions regarding sampling and equilibration times, 
implying serious concerns and weaknesses. All other methods using various 
tracers, multiple sampling techniques, longer equilibration times, or analysis 
of kinetics contradict the existence of a fluid-consuming third space. 
Chappel D et. al.
36
 concluded  that a classic third space per se quantitatively 
does not exist. It is currently not more than an ill-defined compartment 
thought to reflect an otherwise unexplainable perioperative fluid shift.  
An extension of the milliliter-per-kilogram approach to fluid 
administration has been to examine whether higher (e.g., 12 to 18 ml/kg/hr 
of intraoperative crystalloid) or lower (5 to 7 ml/kg/hr) fluid doses in the 
immediate peri-operative phase are associated with benefit after major 
surgery. Unfortunately, this work has been hampered by widely varying 
definitions of “restrictive/ conservative,” “standard,” and “liberal,” differing 
fluid types (colloids/crystalloids) examined, and different time courses over 
which the fluid strategy is applied. A common theme is that when fluid is 
given based on a milliliter-per-kilogram protocol and on clinical assessment 
rather than to target defined physiologic endpoints, the administration of 
more than 3500 to 5000 ml of crystalloid solution in the immediate 
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perioperative period is associated with increased postoperative morbidity. 
This may be reflected in increased weight gain, cardiopulmonary 
dysfunction, impaired wound healing, delayed GI function, and increased 
hospital length of stay .One study gives apparently conflicting 
results
37
although this may be partly accounted for by methodological 
differences with the other studies here. 
Modern Fluid Management
38
 
The modern approach to fluid management is based on the concept of 
goal-directed therapy (GDT), in which it is believed that interventions 
should be performed specifically to affect a meaningful clinical variable. It 
is based on measuring key physiologic variables related to cardiac output or 
global O2 delivery and administering fluids to manipulate these variables 
toward levels associated with improved tissue perfusion and clinical 
outcome. The reality is that fluids can be harmful, and should only be given 
when they are expected to produce some benefit.  Optimization of stroke 
volume using appropriate fluid management is the desired goal of peri-
operative fluid therapy. 
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Newer monitoring tools like Oesophageal  Doppler Monitoring and 
optimization off Respiratory Variation are being increasingly recommended 
to guide fluid therapy.  
Figure  3  :  Protocol for ODM-based intraoperative goal-directed fluid 
therapy. 
 
FTc, Heart rate-corrected descending aorta flow time; SV, stroke volume. 
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CHAPTER 6 
PERIOPERATIVE FLUID ASSESSMENT
39
 
Accurate assessments of intravascular fluid status are an essential part 
of perioperative care since it is a key variable influencing cardiac output 
(preload), and therefore tissue O2 delivery.   
Assessment of Fluid Status by Physical Examination 
Obvious hypovolemia may manifest with tachycardia, reduced pulse 
pressure, hypotension, and increased capillary refill time. Examination of 
neck veins and passive leg raising test can yield useful information. The 
passive leg raising test (PLR) delivers a reversible endogenous fluid 
challenge by increasing venous return resulting from elevating the legs to 45 
degrees in a supine patient and evaluating its effect on blood pressure and 
heart rate.  
Invasive Pressure Monitoring 
Central Venous Pressure (CVP) 
CVP is a reasonable surrogate for the corresponding right atrial 
pressures. Single point estimates of CVP are of limited clinical value unless 
they are low (<5 mm Hg) and confirm an existing suspicion for 
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hypovolemia. Trends of CVP  and their correspondence to clinical evidence 
of organ function and perfusion help to create a more meaningful picture of 
fluid needs and euvolemia.  
Pulmonary Artery Catheters (PACs) and Pulmonary Artery Occlusion 
(Wedge) Pressures 
Pulmonary artery catheterization is an attractive option to measure 
both right and left heart and pulmonary artery pressures. Use of PACs has 
fallen over the last ten years due  to  higher complication rates, frequent 
misinterpretation of PAC data , and relative success with CVP-based 
methods for resuscitation in septic shock .  
Cardiorespiratory Interactions and Dynamic Analysis of Fluid Status 
Cardiac output and blood pressure interact with the respiratory system 
in a predictable manner. Indices of intravascular fluid and preload 
assessment derived from positive pressure ventilator-induced arterial blood 
pressure changes include systolic pressure variability, the respiratory 
systolic variation test, stroke volume variability, and respiratory changes in 
arterial pulse pressure. Transthoracic echo offers a noninvasive and portable 
means of assessing fluid status. 
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CHAPTER 7 
LIBERAL VS RESTRICTIVE FLUID PROTOCOL 
Fluid management in the perioperative period has been extensively 
studied but, despite that, “the right amount” still remains uncertain. Over the 
last few decades, these circumstances lead to two “styles” of fluid 
management:  the “LIBERAL” AND “RESTRICTED” fluid 
administration.  
A standardized quantitative definition of the “liberal” and “restricted” 
fluid administration  still remain uncertain. There are only heterogeneous 
examples in the literature. 
Table 2  :  Liberal and  Restricted fluid administration 
 Liberal Restricted 
Holte et al.40 30 ml/Kg/h 10 ml/Kg/h 
Holte et al.41 18 ml/Kg/h RL + 7 ml/Kg/h 
HES  
5-7 ml/Kg/h RL + 7 ml/Kg/h 
HES  
Abraham-Nordling M. et 
al.42 
5 ml/Kg/h RL + 2 ml Gluc 
2.5% 
2 ml/Kg/h Gluc 2.5% 
Lobo S. et al.43 12 ml/Kg/h RL 5 ml/Kg/h RL 
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              Chappell discussion about the type and duration of surgery 
36 
stated 
that a differentiation has to be made between major and minor operations as 
well as abdominal versus non-abdominal. In  high risk surgical patients  
undergoing an intermediate to major risk surgery, evidence suggests  the 
application of  goal directed therapy (GDT), in which fluid administration is 
targeted on hemodynamic parameters (i.e. stroke volume) with the aim to 
maximize the oxygen delivery
44
 . This approach should be the best thing to 
do, but there are limitations like invasiveness and the poor accuracy and 
precision of the non-invasive devices. In moderate to high risk patients 
undergo major surgery expected to last  more  than  180 minutes, a Goal 
Directed fluid Therapy (GDT)  could reduce complications. Finally, several 
studies suggest that in low-risk patients undergoing minor to intermediate 
risk surgery and surgery in ambulatory setting,  liberal strategy (non-
restrictive) may be preferable. It reduces some postoperative complications 
such as nausea, vomiting, drowsiness, dizziness and length of stay
45,
 
46
. 
              Current evidence suggests that liberal fluid is a good idea where 
major trauma and fluid shifting are unlikely, but more careful fluid 
management may be beneficial in more stressful operations.  
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Figure 4  : Hemodynamic monitoring  on the basis of patient risk, 
surgical type and time. 
     
 
 
  
34 
Figure 5 : Intra-operative Fluid approach 
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Figure 6 : Perioperative fluid therapy 
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CHAPTER 8 
REVIEW OF LITERATURE 
Suntheralingham Yogendran, M.D.( 1995) et al 
11
 
This study investigated the impact of  peri-operative fluid status on 
adverse clinical outcomes in ambulatory surgery. Two hundred ambulatory 
surgical patients were prospectively randomized into two groups to receive 
high (20 mL /kg) or low (2 mL /kg) infusions of isotonic electrolyte solution 
over 30 min preoperatively. A standardized balanced anesthetic was used. A 
minimal amount of fluid was given during the intraoperative and 
postoperative periods. Adverse outcomes were assessed by an investigator 
blinded to the fluid treatment group at 30 and 60 min after surgery, at 
discharge, and the first postoperative day.  The incidence of thirst, 
drowsiness, and dizziness was significantly lower in the high-infusion group 
at all intervals. Perioperative hydration of 20 mL/kg for patients undergoing 
general anesthesia for short ambulatory surgery was recommended in this 
study. 
Ali S.Z et al (2003) et al 
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This prospective, double-blinded, randomized controlled study was 
carried out in eighty patients attending for laparoscopic cholecystectomy or 
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gynaecological surgery. They were randomly allocated to receive 2 ml/kg 
(conservative) or 15 ml/kg (supplemental) Hartmann's solution 
intravenously, shortly before induction of anaesthesia. During surgery, fluid 
management was identical in both groups. During the first post-operative 24 
h, post-operative nausea and vomiting occurred in 73% of patients in the 
conservative fluid group and 23% in the supplemental fluid group . It was 
concluded that supplemental pre-operative fluid is an inexpensive and safe 
therapy for reducing post-operative nausea and vomiting.   
Maharaj C.H. et al ( 2005
)48    
A Randomized study was conducted on eighty patients undergoing 
gynecologic laparoscopy. Patients received either large (2 ml/kg per hour 
fasting) or small (3 ml/kg) volume infusions of compound sodium lactate 
solution over 20 min preoperatively. A standardized balanced anesthetic was 
used. The incidence and severity of PONV and pain, and need for 
supplemental antiemetic and analgesic therapy, were assessed by a blinded 
investigator at 0.5, 1, and 4 h postoperatively, and on the first and third 
postoperative days. The incidence and severity of PONV were significantly 
reduced in the large volume infusion group (59%) compared to small 
volume infusion group (87%). Postoperative pain scores and supplemental 
analgesia were also decreased in large volume infusion group. The study 
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concluded that preoperative correction of intravascular volume deficits 
effectively reduced PONV and postoperative pain in high risk patients 
presenting for ambulatory surgery. 
Chaudhary et al (2008)
49  
This prospective randomized clinical trial was conducted on 60 
female patients undergoing elective open cholecystectomy. Patients were 
randomly allocated to three equal groups A, B and C.  All patients received 
pre-operative fluid supplementation. Group A patients received 2 ml/kg 
Ringer lactate iv (intravenously) and served as control, Group B patients 
received 12 ml/kg Ringer lactate iv whereas Group C patients received 12 
ml/kg of 4.5 per cent hydroxyethylstarch (Hetastarch) iv. All patients 
received intra-operative fluid replacement by Ringer’s lactate (6 ml/kg/h). 
An independent blinded observer assessed PONV during first 24 h 
following surgery using visual analogue scale (VAS). VAS scores in Groups 
B and C patients were less than that of Group A patients and became 
significantly different at 4 h post-operatively. The VAS scores of Groups B 
and C patients were comparable throughout. Rescue antiemetic was  
required in 90% of patients  as compared to 50 and 55 per cent patients in 
Group B and Group C, respectively. Pre-operative intravenous fluid 
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supplementation using crystalloids and colloids resulted in significantly 
decreased incidence of PONV. 
Adanir Tayfun et al (2008)
50 
 This study evaluated the effect of preoperative and intraoperative 
hydration (the necessary amount of fluid preoperatively to cover the fluid 
deficit) on PONV. The patients were randomly assigned to one of two 
groups, each having 104 patients. Group 1 received intraoperative volume 
replacement and Group-II received preoperative volume replacement. 
Postoperative antiemetic efficacy was assessed by the ratio of the patients 
that require an antiemetic over the whole group. The PONV was 
significantly less detected in  Group 2 (48%)  than Group 1 (64%). The 
study concluded that PONV was reduced when the fluid deficit was 
replaced preoperatively. 
Ahmed Turkistani et al (2009)
51
 
This study was carried out on 80 patients who underwent 
Laparoscopic cholecystectomy. The patients were divided into four groups 
(each 20 patients), to receive preloading of intravenous fluid, as follows: 
Group 1 received 10 ml/kg of  low-MW tetrastarch in saline, group 2 
received 10 ml/kg medium-MW pentastarch in saline, group 3 had  10 ml/kg 
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of high-MW heta-starch in saline  and group 4 received 10 ml/kg Ringer 
lactate  and this was considered as the control group. All patients received 
the standard anesthetic technique. Postoperatively, the need for antiemetics 
and/or analgesics was recorded and the incidence of PONV was recorded at 
two and 24 hours. The highest incidence of PONV was in group 3 (75% of 
the patients) compared to the other three groups and the need for antiemetic 
therapy was highest in group 3 (70%), followed by group 2 (60%), and then 
group 1(35%), and the least one was in the control group (25%). It was 
concluded that Preoperative fluid supplementation with LR, in a dose of 10 
ml/kg, produced a lower incidence of  PONV compared to colloid solutions. 
Tetrastarch could be a good alternative to LR, for prevention of PONV, due 
to its long lasting effect, up to 24 hours, postoperatively. 
Gaurav Chauhan et al ( 2013)
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This prospective, randomized, double blinded study was conducted in 
200 patients in the age group 20-40 years undergoing ambulatory 
gynaecological laparoscopic surgery. They were randomized into two equal 
groups. Intra-operatively, Group I received 10 ml/kg Compound Sodium 
Lactate and Group II received 30 ml/kg Compound Sodium Lactate. In the 
first 4 h after anaesthesia, the incidence of nausea and vomiting in Group I 
was 66% as compared to 40% in Group II. Anti-emetic use was less in the 
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group II (13%)  as compared to Group I(20%).  This study concluded that 
intravenous hydration is a safe and effective means of preventing PONV 
and ensuring patient satisfaction at the time of discharge. 
Selcuk Yavuz et al (2014)
53
  
This study investigated the effects of preoperative intravenous 
hydration on postoperative nausea and vomiting in high APFEL  scored 
patients undergoing laparoscopic cholecystectomy surgery. It was 
performed in  50 female patients who had APFEL score 3-4. The patients 
were divided into 2 groups.  Group 1 had 15 ml/kg of Ringer Lactate and 
Group 2 received 2ml/kg 0f Ringer lactate .In group 1 , the nausea VAS 
score was lower. When the total number of patients who had nausea and 
vomiting,  more patients suffered nausea in Group II. Hence the study stated 
that Preoperative hydration may be effective in high APFEL scored patients 
to prevent postoperative nausea. 
Chohedri et al (2006)54  
This prospective randomized double-blind study was carried out in 
two hundred ambulatory surgical patients. They were randomly assigned 
into two groups. Before induction of anesthesia Group A received 20 ml/kg 
of 0.9% sodium chloride and Group B received 2 ml/kg of 0.9% sodium 
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chloride over 30 minutes. A standard general anesthetic technique was used. 
The following adverse postoperative outcomes like nausea, vomiting, 
dizziness, and thirst were assessed at 30 and 60 minutes postoperatively and 
at discharge. The incidence of postoperative vomiting and thirst was 
significantly decreased in group A compared to group B (p = 0.014 and p = 
0.029, respectively). There was no difference in the incidence of nausea and 
dizziness between the two groups. This study concluded that preoperative 
high dose hydration  can efficiently decrease the incidence of postoperative 
thirst and vomiting within the first 60 minutes in ambulatory surgeries  . 
Apfel CC et al(2012)
55 
 performed a literature search using 
CENTRAL, MEDLINE, EMBASE, CINAHL, and Web of Science. They 
included prospective randomized controlled trials that reported PONV event 
rates in patients receiving supplemental i.v. crystalloids or a conservative 
fluid regimen after elective surgery under general anaesthesia. Studies were 
evaluated and the following results were given. Compared with conservative 
fluids, i.v. crystalloids reduced the risk of early postoperative nausea   
(P=0.003), late nausea ( P=0.004), and overall nausea (P=0.02). I.V. 
crystalloids did not reduce the risk of early postoperative vomiting (P=0.16) 
or late post-operative vomiting (P=0.09) but reduced overall vomiting  
(P=0.004). I.V. crystalloids did not reduce the risk of early PONV ( P=0.16)  
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but  reduced the risk of late PONV (P<0.001) and overall PONV (P=0.003). 
I.V. crystalloids reduced the need for antiemetic rescue treatment  
(P<0.001). It concluded that supplemental i.v. crystalloids were associated 
with a lower incidence of several PONV outcomes.  
Holte K et al(2004)
56
compared  intraoperative administration of 40 
mL/kg with 15 mL/kg LR in 48  patients undergoing laparoscopic 
cholecystectomy. He concluded that intraoperative administration of 40 
ml/kg compared with 15 ml/kg LR improves postoperative organ functions 
and recovery and shortens hospital stay. Nausea, general well-being, thirst, 
dizziness, drowsiness, fatigue, and balance function were also significantly 
improved, as well as significantly more patients fulfilled discharge criteria 
and were discharged on the day of surgery with the high-volume fluid 
substitution. 
Brandstrup et. al (2003)
57
compared a liberal vs. restrictive fluid 
strategy in 172 patients undergoing colorectal surgery. The liberal patients 
received 500 ml of 6% HAES and 500 ml NS loading, followed by NS at 7 
ml/kg/h for one hour, then 5 ml/kg/hr for two hours, then 3 ml/kg/hr 
afterwards, with 500 ml blood loss replaced by NS, 500-1500 ml EBL 
replaced with 6% HAES, and over 1500 ml replaced with blood 
components. The restrictive group, by contrast, received only 500 ml of 
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D5W (minus whatever oral intake occurred during fasting) and volume to 
volume blood loss with 6% HAES up to 1500 ml EBL. Total IV fluids 
average 5.4 L for the liberal group and 2.7 L for the restrictive group. The 
restrictive regimen appeared to reduce the incidence of major and minor 
complications (ex. anastomotic leakage, pulmonary edema, pneumonia, and 
wound infection). More specifically, the numbers of both cardiopulmonary 
(7% versus 24%, P = 0.007) and tissue-healing complications (16% versus 
31%, P = 0.04) were significantly reduced. No patients died in the restricted 
group compared with 4 deaths in the standard group (0% versus 4.7%,  
P = 0.12). Despite a perioperative decrease in urine output, acute renal 
failure did not occur in any patient. However, Brandstrup’s data was 
confounded by the introduction of colloids, as colloids were predominantly 
given to the restrictive group and the liberal group received > 5 L 
crystalloids.  
Nisanevich et. al(2005)
58
 
Nisanevich et al. randomized 152 patients undergoing various 
abdominal procedures to receive intra-operatively either liberal (10 ml/kg 
bolus followed by 12 ml/kg/hr) vs. restrictive (4 ml/kg/hr) amount of 
lactated ringers solution. The number of patients with complications was 
lower in the RPG (P = 0.046). They found decreased postoperative 
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morbidity (including improved GI recovery and a shortened hospital stay), 
under a protocol-based, more restrictive fluid therapy (1.2 L vs.  
3.7 L). 
McCaul et al(2003)
59
 compared iv fluid loading with and without 
supplementary dextrose for the prevention of postoperative nausea and 
vomiting (PONV). 120 ASA I female patients undergoing elective 
gynecological laparoscopy were randomized to one of three groups, and 
received either: (a) CSL 1.5 ml/kg per hour fasting duration; (b) CSL, 1.5 
mL/kg per hour fasting duration with 0.5 g/kg dextrose added in 50% 
formulation (CSL/dextrose); or (c) no iv fluid (control).  The CSL/dextrose 
group  reported increased  PONV episodes,pain and thirst  compared to 
control. They concluded that administration of dextrose is associated with 
nausea, increased opioid requirement and late thirst after elective 
gynecological laparoscopy and iv fluids did not decrease PONV. 
Holte K et al(2007)
41
 investigated the effects of two regimens of 
intraoperative fluids with physiological recovery as the primary outcome 
measure after fast-track colonic surgery. 32 ASA I-III patients undergoing 
elective colonic surgery were randomized to 'restrictive'(median 1640 ml, 
range 935-2250 ml) (Group 1) or 'liberal' (median 5050 ml, range 3563-
8050 ml) (Group 2) perioperative fluid administration. A 'restrictive' fluid 
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regimen led to a transient improvement in pulmonary function and 
postoperative hypoxemia but no other differences in all-over physiological 
recovery compared with a 'liberal' (corrected) fluid regimen after fast-track 
colonic surgery. 
Abraham Nordling M et al(2012)
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trial was conducted to examine 
whether an extremely restricted perioperative fluid protocol would reduce 
hospital stay beyond the existing fast-track hospital time of 7 days after 
surgery. Seventy-nine patients were randomized to restricted and 82 to 
standard fluid therapy. Patients in the restricted group received a median of 
3050 ml fluid on the day of surgery compared with 5775 ml in the standard 
group (P < 0.001). The proportion of patients with complications was 
significantly lower in the restricted group (31 of 79 versus 47 of 82; P = 
0.027) 
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CHAPTER 9 
MATERIALS AND METHODS 
This was a prospective randomized study done on patients undergoing 
puerperal sterilization under GA as day care procedure in Government 
RSRM Lying-in Hospital, Chennai. 
After obtaining the approval of the Institutional Ethical Committee, a 
randomized, prospective study was conducted on 102 patients over a period 
of  six months. 
INCLUSION CRITERIA 
ASA PS 1 and 2 patients aged between 18 and 40 years undergoing 
puerperal sterilization under GA as day care procedure. 
EXCLUSION CRITERIA 
1. BMI > 30 
2.  Smokers 
3. History of Motion Sickness 
4. Unstable haemodynamics  
5. Systemic Illness involving renal, cardiac, GIT and nervous system  
6. Diseases complicating pregnancy 
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GROUPS 
• Group R (Restrictive Fluid Protocol) patients received 2 ml /kg of 
Ringer Lactate.  
• Group L (Liberal Fluid Protocol) patients received 15 ml/kg of 
Ringer Lactate.  
MONITORING 
ECG, ANIBP, SaO2, ETCO2, Temperature 
METHODOLOGY 
After ethical committee approval and written consent, ASA PS 1 and 
2 patients aged between 18 and 40 years, undergoing puerperal sterilization 
under GA as day care procedure and meeting inclusion criteria were drafted 
into the study. The exclusion criteria were  BMI > 30,  Smokers, History of 
Motion Sickness, Unstable haemodynamics, Systemic Illness involving 
renal, cardiac, GIT and nervous system and Diseases complicating 
pregnancy.  
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SAMPLE SIZE AND RANDOMIZATION 
Based on the previous study
48
 with a statistical power of 95% and an 
alpha error of 0.05, the sample size was calculated to be 102. Patients were 
randomized into 2 groups of 51 each by computer generated randomization 
from website www.randomizer.org generated by a biostatistician not 
directly involved in the study.            
Once patients were co-opted for the study, they were assessed 
preoperatively by an anaesthesiologist and relevant investigations were 
ordered in keeping with the institution protocols. The patients were 
familiarized with the use of VAS scale. In the premedication room, IV line 
was established and standard monitors applied included ECG, ANIBP, 
SaO2, ETCO2 and temperature using a L&T Star 60 monitor. 
             An anaesthesiologist  opened  the randomization cover and based on 
the group allocation,  administered the prescribed fluid intervention. Group 
R (Restrictive fluid protocol) patients received 2ml/kg of Ringer Lactate 
over 20 minutes. Group L (Liberal fluid protocol) patients received 15 ml/kg 
of Ringer Lactate in a similar manner. This anaesthesiologist no longer 
participated in the study.   
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In the OT, a different anaesthesiologist blinded to the preloading 
recorded  the baseline haemodynamic parameters and re-oriented the patient 
to the use of VAS scale. Preoxygenation was done with 100% oxygen. 
General anaesthesia was induced with Inj. Glycopyrollate 0.2 mg, Inj. 
Midazolam 0.02 mg/kg, Inj. Pentazocine lactate 0.5 mg/kg and Inj. 
Ketamine hydrochloride 1.5 mg/kg given intravenously. Oxygen was 
administered with a facemask and ventilation was assisted as necessary. 
After assessing adequate depth of anaesthesia, surgery was started, and 
anaesthesia was supplemented as necessary, with boluses of Inj. Ketamine 
0.5 mg/kg. Intra-operative fluid was administered in the form of Ringer 
Lactate at 2ml/kg/hour. After completion of surgery, the wound was 
infiltrated with 0.5% Bupivacaine 5 ml. Intra-operatively,  haemodynamics 
and any adverse events during the course of surgery were noted. 
Post-operatively, patient received Oxygen by Hudson mask at 4 
L/min for 4 hours. Ringer lactate was  administered at 2 ml/kg/hour for 6 
hours and then discontinued. If the patient felt comfortable she was allowed 
to take water orally. The quantity and frequency were determined by the 
patient’s needs. If patient developed vomiting, Inj. Ondansetron 4 mg was  
administered as rescue anti-emetic. If vomiting continued, oral water was  
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discontinued and Ringer Lactate started at 2 ml/kg /hour. Subsequent 
assessment was made at 12 hour and 24 hours. 
DATA CAPTURE AND INTERPRETATION 
Post-operatively patient was assessed at 2, 6, 12 and 24 hours by an 
anaesthesiologist who has not participated in the study. Pain was assessed 
using the VAS scale. When VAS score  was more than 5, or patient 
demanded, rescue analgesic  was administered in the form of Inj. Tramadol 
50 mg slow IV. 
Figure 7 :  VAS Scale For Pain 
 
             Nausea, when solicited during assessment by the research 
personnel, is defined as the urge to vomit. It is scored with a four-point 
numerical scale from 0 to 3, with 0 - no nausea, 1 - mild nausea, 2 - 
moderate nausea, and 3 - severe nausea. Incidence of PONV from 0-2 hours 
post-operatively is labeled as ‘early PONV’ and that after two hours is 
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labeled as ‘late PONV’. Inj.Ondansetron 4 mg IV is used as a rescue 
antiemetic.  
Table 3 :  4 POINT PONV SCALE 
4 POINT PONV SCALE 
0 NO Nausea 
1 MILD Nausea 
2 MODERATE Nausea 
3 SEVERE Nausea 
 
            Post-operative Ileus was recorded by a history of passing flatus, 
auscultation of bowel sounds and defecation. 
            Post-operative ambulation and exercise capacity was  tested at 12 
and 24 hours by the validated TUG test (timed Up and Go test). It consists 
of patient being seated on the bed, getting off it, walking 3 meters turning 
walking back to the bed and seating themselves on the bed. The time taken 
will be recorded. 
            General Well Being of the patient was recorded by asking for 
symptoms of Thirst, Dizziness, Headache, Drowsiness and Fatigue. 
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Presence of symptoms is indicated by 1 point and the absence by 0 point. A 
score of ≤ 2 is considered as good general condition. 
Discharge criteria is assessed using the  Post Anaesthetic Discharge 
Scoring System. Out of a total score of 10, a score of ≥8 is considered fit or 
discharge. 
Table 4 : Post Anaesthetic Discharge Scoring System 
PADSS SCALE 
 2 1 0 
Vital signs Within 20 % of 
baseline 
20 - 40% >40% 
Activity& 
Mental status 
Oriented X 3 and 
steady gait 
 
Oriented X 3 or 
steady gait 
 
Neither 
Pain, PONV Minimal Moderate, 
received 
treatment 
Severe, 
Receiving 
treatment 
Surgical 
Bleeding 
Minimal Moderate Severe 
Intake/ Output PO fluid and 
voided 
PO fluids or  
Voided 
Neither 
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CHAPTER  10 
OBSERVATION AND ANALYSIS 
The information gathered from the selected cases were noted in the 
master chart. The collected data were analyzed with IBM.SPSS Statistics 
software 23.0 Version. To describe about the data, descriptive statistics, 
frequency analysis, percentage analysis were used for the categorical 
variables and the mean and standard deviation were used for continuous 
variables. To find the significant difference between the bivariate samples in 
Independent groups the Unpaired sample t-test was used. To find the 
significance in categorical data Chi-Square test and Fisher's exact test was 
used. In all the above statistical tools the probability value of <0.05 is 
considered as significant. 
This study was designed to compare the effect of “liberal vs. 
restrictive” fluid protocol on post-operative nausea vomiting and discharge 
criteria in patients undergoing puerperal sterilization under GA as day care 
surgery 102 patients were selected and randomized. 
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DEMOGRAPHIC PROFILE 
AGE DISTRIBUTION 
Table 5 :  Distribution of Age 
AGE DISTRIBUTION 
Age(in years) GROUP    GL GROUP  GR 
Mean 25.94 25.47 
S.D 3.301 3.331 
‘p’ value             0.475 
 
Figure   8 :   Age Distribution 
 
The mean age of patients in Group GL was 25.94.In GR Group , the 
mean age of patients was 25.47. The age group ‘p’ value is 0.475 which is 
statistically not significant. 
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WEIGHT DISTRIBUTION 
                                   Table  6 : Distribution of Weight 
WEIGHT  DISTRIBUTION 
Weight(in kgs) GROUP    GL GROUP  GR 
Mean 53.20 52.67 
S.D 8.355 7.536 
‘p’ value            0.738 
 
Figure 9 : Comparison of  Weight 
 
The mean weight of patients in Group GL was 53.20. In Group GR, 
the mean weight of patients was found to be 52.67.  The ‘p’ value is 0.738 
which is statistically not significant. 
 
53.20 
52.67 
50.00
50.50
51.00
51.50
52.00
52.50
53.00
53.50
GL GR
WEIGHT 
57 
BMI DISTRIBUTION 
Table 7 :  Distribution of BMI 
BMI DISTRIBUTION 
BMI (in kg/m
2
) GROUP    GL GROUP  GR 
Mean 22.28 22.77 
S.D 3.208 3.374 
‘p’ value              0.453 
 
Figure 10 : Comparison of  BMI 
            
The mean BMI of patients in Group GL was 22.28. In Group GR, the 
mean BMI of patients was 22.77. The ‘p’ value is 0.453 which is 
statistically not significant. 
22.28 
22.77 
20.00
20.50
21.00
21.50
22.00
22.50
23.00
GL GR
BMI 
58 
DURATION OF SURGERY 
Table 8 : Duration Of Surgery 
DURATION OF SURGERY 
Duration of surgery (minutes) GROUP    GL GROUP  GR 
Mean 17.45 17.94 
S.D 2.524 2.485 
‘p’ value    0.325 
  
Figure 11 : Duration Of Surgery 
 
The mean duration of surgery  in Group GL was 17.45 minutes. In 
Group GR, the mean  duration of  surgery  was 17.94 minutes. The  ‘p’ 
value is 0.325 which is statistically not significant. 
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ASA DISTRIBUTION 
Table 9 : ASA Distribution 
ASA  DISTRIBUTION 
 GROUP GL GROUP GR 
 No.of patients % No.of patients % 
PS I 36 70.6 32 62.7 
PS II 15 29.4 19 37.3 
TOTAL 51 100 51 100 
‘p’ value 0.529 
 
Figure 12 : Comparison of ASA Distribution 
 
          In Group GL, the no. of patients in PS I is 36 which is 70.6% and  the 
no. of patients in PS II is 15 which is 29.4%. In Group GR, the no. of 
patients in PS I is 32 which is 62.7% and the no. of patients in PS II is 19 
which is 37.3%. The ‘p’ value was found to be 0.529 which is statistically 
not significant. 
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COMPARISON OF  VAS 
Table   10  :   Comparison of  VAS 
COMPARISON OF VAS 
 GROUP GL GROUP GR  
VAS Mean SD Mean SD ‘p’ VALUE 
2 hours 1.75 0.771 3.14 0.693 0.0005 
6 hours 1.08 0.688 2.31 0.735 0.0005 
12 hours 0.45 0.610 1.37 0.747 0.0005 
24 hours 0.20 0.401 0.71 0.576 0.0005 
 
Figure 13 : Comparison of  VAS 
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 In GL group, the mean VAS score at 2 hours was 1.75. At 6 hours, 
the mean VAS score was 1.08.At 12 hours the mean VAS score was 0.45. 
At 24 hours the mean VAS score was 0.20. 
 In GR Group, the mean VAS score at 2 hours was 3.14. At 6 hours, 
the mean VAS score was 2.31.At 12 hours the mean VAS score was 1.37. 
At 24 hours the mean VAS score was 0.71. 
The ‘p’ value at 2, 6 12, 24 hours was found to be 0.0005 respectively 
which is statistically significant. 
POSTOPERATIVE NAUSEA AND VOMITING 
Table 11 : Comparison of  PONV 
COMPARISON OF PONV 
 GROUP GL GROUP GR  
PONV Mean SD Mean SD ‘p’ VALUE 
2 hours 0.25 0.440 1.53 0.612 0.0005 
6 hours 0.06 0.238 1.18 0.434 0.0005 
12 hours 0.02 0.140 0.71 0.460 0.0005 
24 hours 0.02 0.140 0.10 0.300 0.094 
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Figure 14 : Comparison of PONV 
 
In GL group, the mean PONV score at 2 hours was 0.25. At 6 hours, 
the mean PONV score was 0.06.At 12 hours the mean PONV score was 
0.02. At 24 hours the mean PONV score was 0.02. 
 In GR Group, the mean PONV score at 2 hours was 1.53. At 6 hours, 
the mean PONV score was 1.18.At 12 hours the mean PONV score was 
0.71. At 24 hours the mean PONV score was 0.10. 
 The ‘p’ value at 2, 6, 12 hours was found to be 0.0005 respectively 
which is statistically  significant   and at 24 hours the ‘p’ value is 0.094 
which is statistically  not significant. 
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PADSS 
                               Table 12 : Comparison of PADSS 
COMPARISON OF PADSS 
 GROUP GL GROUP GR  
PADSS Mean SD Mean SD ‘p’ VALUE 
2 hours 6.96 0.599 6.18 0.478 0.0005 
6 hours 8.12 0.431 7.04 0.344 0.0005 
12 hours 9.24 0.619 8.76 0.790 0.0002 
24 hours 10.00 0.000 9.67 0.476 0.0005 
 
Figure 15 : Comparison of PADSS 
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 In GL Group, for Post Anaesthetic Discharge Scoring System, the 
mean score  at 2 hours was 6.96. At 6 hours, the mean score was 8.12. At 12 
hours the mean was 9.24. At 24 hours the mean was 10.00. 
 In GR Group, for Post Anaesthetic Discharge Scoring System, the 
mean score at 2 hours was 6.18. At 6 hours, the mean score was 7.04. At 12 
hours the mean score was 8.76 . At 24 hours the mean score was 9.67. 
 The ‘p’ value at 2,6,24 hours was found to be 0.0005 respectively and 
at 12 hours the ‘p’ value is 0.002 which is statistically significant. 
TUG TEST 
Table 13 : Comparison of TUG TEST 
TUG TEST 
 GROUP GL GROUP GR  
TUG TEST 
(seconds) 
Mean SD Mean SD ‘p’ VALUE 
12 hours 37.51 8.561 40.16 8.900 0.129 
24 hours 15.63 5.181 16.73 4.418 0.252 
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Figure 16 : Comparison of TUG test 
 
In GL Group, at 12 hours the mean duration for tug test was 37.51 
seconds. At 24 hours the mean duration was 15.63 seconds.  
In GR Group, at 24 hours the mean duration for tug test was 40.16 
seconds. At 24 hours the mean duration was 16.73 seconds.   
The ‘p’ value at 12 and 24 hours was found to be 0.129 and 0.252 
which is statistically not significant. 
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THIRST 
Table 14 : Comparison of Thirst 
THIRST 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
 
0.000 
 
2 
Yes 18 35.3% 39 76.5% 
No 33 64.7% 12 23.5% 
 
6 
Yes 14 27.5% 26 51.0%  
0.015 No 37 72.5% 25 49% 
 
12 
Yes 5 9.8% 11 21.6%  
0.102 No 46 90.2% 40 78.4% 
 
24 
Yes 3 5.9% 9 17.4%  
0.122 No 48 94.1% 42 82.4% 
 
Figure 17 : Comparison of Thirst 
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At 2 hours, in Group GL, 18 patients( 35.3% ) had thirst while in 
Group GR , 39 patients had thirst ( 76.5%) . At 6 hours, in Group GL, 14 
patients(27.5%) had thirst while in Group GR,  26 patients had thirst  
(51.0%). At  12 hours, in Group GL, 5 patients(9.8% ) had thirst while in 
Group GR, 11  patients had thirst ( 21.6%) . At  24 hours, in Group GL, 3 
patients(5.9% ) had thirst while in Group GR,  9  patients had thirst  
(17.4%). 
 The ‘p’ value for thirst at 2 and 6 hours was found to be 0.000 and 
0.015 respectively which is statistically significant. The ‘p’ value for thirst 
at 12 and 24 hours was found to be 0.102 and 0.122 respectively which is 
statistically not significant. 
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DIZZINESS 
Table 15 : Comparison of Dizziness 
DIZZINESS 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
 
0.234 
 
2 
Yes 4 7.8% 9 17.6% 
No 47 92.2% 42 82.4% 
 
6 
Yes 5 9.8% 7 11.8%  
0.539 No 46 90.2% 49 88.2% 
 
12 
Yes 2 3.9% 0 0%  
0.495 No 49 96.1% 51 100% 
 
24 
Yes 1 2% 1 2%  
1.000 No 50 98% 50 98% 
 
Figure 18 : Comparison of Dizziness 
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At 2 hours, in Group GL, 4 patients (7.8% ) had dizziness while in 
Group GR,  9 patients had dizziness ( 17.6%) . At 6 hours, in Group GL, 5 
patients( 9.8% ) had dizziness while in Group GR, 7 patients had dizziness  
(11.8%) . At 12 hours, in Group GL, 2  patients (3.9%) had dizziness while 
in Group GR,  none had dizziness ( 17.6%) . At 24 hours, in Group GL and 
GR,   1 patient each complained of dizziness (2%) . The ‘p’ value for 
dizziness at  2, 6, 12 and 24   hours was found to be 0.234 , 0.539, 
0.495,1.000  respectively which is statistically not significant. 
DROWSINESS 
Table 16 : Comparison of Drowsiness 
DROWSINESS 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
 
0.436 
 
2 
Yes 2 3.9% 5 9.8% 
No 49 96.1% 46 90.2% 
 
6 
Yes 1 2.0% 7 13.7%  
0.060 No 50 98.0% 44 86.3% 
 
12 
Yes -  - -  
- No 51 100% 51 100% 
 
24 
Yes -  - -  
- 
 
No 51 100% 51 100% 
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Figure 19 : Comparison of Drowsiness 
 
At 2 hours, in Group GL,  2  patients (3.9%) had drowsiness while in 
Group GR,  5 patients had drowsiness (9.8%) . At 6 hours, in Group GL, 1  
patient (2.0%) had drowsiness while in Group GR, 7 patients had 
drowsiness (13.7%) . At 12 and 24 hours, none of the patient complained of 
drowsiness in both the groups  
The ‘p’ value for drowsiness at 2 and 6 hours was found to  be  0.436 , 
0.060  respectively which is statistically not significant. 
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HEADACHE 
Table 17 : Comparison of  Headache 
HEADACHE 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
 
0.060 
 
2 
Yes 1 2% 7 13.7% 
No 50 98% 44 86.3% 
 
6 
Yes 1 2% 0 0%  
1.000 No 50 98% 51 100% 
 
12 
Yes 3 5.9% 2 3.9%  
1.000 No 48 94.1% 49 96.1% 
 
24 
Yes 1 2% 1 2%  
1.000 No 50 98% 50 98% 
 
Figure 20 : Comparison of Headache 
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At 2 hours, in Group GL, 1 patient ( 2% ) had headache while in 
Group GR,  7 patients had headache ( 13.7%) . At 6 hours, in Group GL, 1 
patient( 2% ) had headache  while in Group GR,  none complained of 
headache. At 12 hours, in Group GL, 3 patients( 5.9% ) had headache while 
in Group GR,  2 patients had headache (3.9%) . At 24 hours, in Group GL 
and GR,  1 patient each complained of headache( 2% )  
 The ‘p’ value for headache at  2,6, 12 and 24   hours was found to  be 
0.060 , 1.000, 1.000,1.000  respectively which is statistically not significant. 
FATIGUE 
Table 18 : Comparison of Fatigue 
FATIGUE 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
1.000  
2 
Yes 4 7.8% 5 9.8% 
No 47 92.2% 46 90.2% 
 
6 
Yes 2 3.9% 7 13.7%  
0.160 No 49 96.1% 44 86.3% 
 
12 
Yes 0 0% 1 2%  
1.000 No 51 100% 50 98% 
 
24 
Yes 0 0% 0 0%  
- No 51 100% 51 100% 
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Figure 21 : Comparison of Fatigue 
 
At 2 hours, in Group GL, 4 patients ( 7.8% ) complained of  fatigue  
while in Group GR,  5 patients had fatigue ( 9.8%) . At 6 hours, in Group 
GL, 2 patients (3.9% ) had fatigue  while in Group GR,  7 patients 
complained of fatigue. At 12 hours, one patient from Group GR complained 
of fatigue. At 24 hours, none of the patients had fatigue in both the groups. 
The ‘p’ value at 2, 6, 12 hours was found to be  1.000,0.160, 1.000 
respectively which is statistically not significant.  
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BOWEL SOUND 
Table 19 – Bowel Sound 
BOWEL SOUND 
Hours  GROUP GL GROUP GR ‘p’ VALUE 
  Number Percentage Number Percentage  
0.436  
2 
Yes 49 96.1% 46 90.2% 
No 2 3.9% 5 9.8% 
 
6 
Yes 51 100% 48 94.1%  
0.243 No 0 0% 3 5.9% 
 
12 
Yes 51 100% 51 100%  
- No 0 100% 0 100% 
 
24 
Yes 51 100% 51 100%  
- No 0 100% 0 100% 
 
Figure 22 : Bowel Sounds 
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At 2 hours, bowel sound was present in 49 patients ( 96.1% ) in 
Group GL and 46 patients (90.2%) in Group GR. At 6 hours, bowel sound 
was present in 51 patients ( 100% ) in Group GL and 48 patients (94.1%) in 
Group GR.  At 12 and 24 hours, bowel sound was present in all patients in 
both the groups. 
The ‘p’ value at 2 and 6 hours was found to be  0.436, 0.243 
respectively which is statistically not significant. 
PASSING FLATUS 
Table 20 : Passing flatus 
                                           PASSING FLATUS 
Hours  GROUP GL GROUP GR ‘p’ 
VALUE 
  Number of 
patients 
% Number 
of patients 
%  
 
 
- 
 
2 
Yes 0 0 0 0 
No 51 100 51 100 
 
6 
Yes 3 5.9 1 2 0.617 
No 48 94.1 50 98 
 
12 
Yes 21 41.2 20 39.2 0.840 
No 30 58.8 31 60.8 
 
24 
Yes 50 98 50 98 1.000 
No 1 2 1 2 
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Figure 23 : Passing flatus 
 
At 2 hours, none of the patients passed flatus in both the groups. At  
6 hours, 3 patients (5.9%) in group GL and 1 patient (2%)from Group GR 
passed flatus. At 12 hours, 21 patients(41.2%) in group GL and 20 
patients(39.2%) in group GR passed flatus. At 24 hours, 50 patients (98%) 
and 50 patients (98%) in group GR passed flatus. 
The ‘p’ value at  6 ,12  and 24 hours was found to be 
0.617,0.840,1.000 respectively  which is statistically not significant. 
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DEFECATION 
Table 21 : Defecation 
DEFFECATION 
Hours  GROUP GL GROUP GR ‘p’ 
VALUE 
  Number of 
patients 
% Number 
of patients 
%  
 
 
- 
 
2 
Yes 0 0 0 0 
No 51 100 51 100 
 
6 
Yes 0 0 0 0  
- No 51 100 51 100 
 
12 
Yes 0 0 2 3.9 0.495 
No 51 100 49 96.1 
 
24 
Yes 22 43.1% 11 21.6 0.200 
No 29 56.9% 40 78.4 
 
Figure 24 : Defecation 
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At 2 hours and 6 hours, none of the patients defecated in both the 
groups. At 12 hours, only 2 patients in group GR( 3.9%)  defecated.. At 24 
hours, 22 patients in group GL (43.1%) and 11 patients in group GR  
(21.6%) defecated. The ‘p’ value  at  12  and 24 hours was found to be 
0.495,0.200  respectively which is statistically not significant. 
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CHAPTER 11 
DISCUSSION 
Modern multivariable studies, meta-analysis and systemic reviews 
have greatly increased our knowledge about the risk factors of PONV. 
Consensus is emerging that antiemetic prophylaxis is neither cost effective 
nor free from side effects. Multimodal management of PONV obviates the 
need of antiemetic prophylaxis and its associated side effects and therefore 
the importance of adequate hydration of patients has been stressed on. 
Adverse outcomes such as nausea, vomiting, thirst, drowsiness, and 
dizziness can create great distress in ambulatory patients. Nausea delays oral 
intake and worsens the general well-being of patients. Retching because of 
nausea may increase pain and cause discomfort after minor abdominal 
surgery, such as laparoscopic procedures. Dizziness can precipitate nausea, 
vomiting, and restlessness and can delay ambulation. Postoperative 
drowsiness is potentially dangerous to patients if they cannot protect their 
airways. It also delays recovery and discharge. These adverse outcomes 
delay early discharge and home readiness, thus increasing the workload of 
the nursing staff.  
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Crystalloid fluid administration may be a simple, inexpensive, non 
pharmacological therapy that could reduce these symptoms, avoiding drug-
related side-effects. The current evidence suggests that liberal fluid is a good 
idea where major trauma and fluid shifting are unlikely, but more careful 
fluid management may be beneficial in more stressful operation.  
This prospective, double-blinded, randomized, comparative study is 
conducted in a common surgery that is conducted extensively across the 
country which would benefit if the patient will achieve discharge criteria at 
the earliest. Govt. RSRM Lying in Hospital is situated in the heart of North 
Chennai. Everyday around 8 to 10 cases of puerperal sterilization are being 
conducted. Patients posted for puerperal sterilization were selected in our 
study from this enormous pool of cases. 
As PONV is affected by so many variables, we tried to ensure 
maximum standardization in our study. In this way, those patients with  
BMI >30 (Obesity), Smokers, History of Motion Sickness, Unstable 
haemodynamics, Systemic Illness involving renal, cardiac, GIT and nervous 
system., Diseases complicating pregnancy were excluded from the study. 
On analyzing the demographic profile, the distribution of age and 
Body Mass Index in both the groups were comparable. The ASA 
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distribution and the mean duration of surgeries were also comparable and 
there was no significant diference between the two groups. 
Intraoperatively, vital parameters were monitored and compared. 
There was no statistically significant difference observed in terms of Heart 
rate, Systolic Blood pressure, Diastolic Blood pressure, Mean Arterial 
Pressure and SpO2 between the two groups. 
Effects on PONV  
Yogendran.S et al
11
 in 1995 compared the effects of high (20 ml/kg) 
and low (2 ml/kg) infusion of isotonic electrolyte solution preoperatively on 
adverse outcomes in ambulatory surgery. They reported a decrease in the 
incidence of PONV.  In our study, the mean PONV scores at 2,6,12 hours in 
Group GL were lesser (0.25±0.44, 0.06±0.238, 0.02±0.140) when compared 
with Group GR (1.53±0.612, 1.18±0.434, 0.71±0.460). There was a 
significant difference between the two groups.  At 24 hours, the mean 
PONV score (GL 0.02±0.14; GR 0.10±0.300) in both the groups was 
comparable and no difference was observed.  Hence our study agrees with 
the above study that liberal fluid improves patient outcomes in short 
procedures. 
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Ali S et al.
47  
  in 2003  have reported that a supplemental preoperative 
I.V. fluid therapy with 15 ml.kg
-1
 significantly reduced the incidence of 
PONV .  PONV occurred in 73% in conservative fluid group and 23% in the 
supplemental group. Our study results correlate with the above study. 
Maharaj.C et al
48
 in 2005 conducted  a randomized  study in eighty 
patients undergoing gynaecological laparoscopy who received either large 
(2 ml/kg/hour fasting)  or small(3 ml/kg) preoperatively. The study 
concluded that  preoperative correction of intravascular volume deficits 
effectively reduced  PONV in high risk patients presenting for ambulatory 
surgery. The result is similar to our study but those at high risk for PONV 
are excluded from our study. 
Chaudhary  et al
49
 in 2008 compared the effects of 2 ml/kg Ringer 
lactate iv (Group A)  , 12 ml/kg Ringer lactate iv (Group B)  and  12 ml/kg 
of 4.5 per cent hydroxyethylstarch (Hetastarch) iv. They concluded that Pre-
operative intravenous fluid supplementation using crystalloids and colloids 
resulted in significantly decreased incidence of PONV.  In our study also we 
found similar results. However, in our study colloid was not used . 
Adanir Tayfun et al (2008)
50 
studied the effect of preoperative and 
intraoperative hydration on PONV. Group I received intraoperative volume 
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replacement and Group-II received preoperative volume replacement .The 
PONV was significantly less detected in Group II (48%) than Group I 
(64%). The study concluded that PONV was reduced when the fluid 
deficit was replaced preoperatively. Our study correlates with his study 
that the incidence of  PONV was decreased in those who received liberal( 
15 ml/kg) fluid pre-operatively. However, in our study intra-operative fluid 
administration is similar in both the groups. Their argument is explained by 
the fact that if the fluid deficit is covered 2 h prior to the operation, the 
crystalloid fluids diffuse outside of the blood vessels into tissues and this 
allows the fluid to restore the deficit at the cellular level which may affect 
both the peripheral (mucosal hypoperfusion of gastrointestinal tract) and 
central (probably the hydration of CTZ cells) mechanisms of PONV. Our 
study did not evaluate this component. 
Ahmed Turkistani et al (2009)
51 
divided  the patients into four 
groups (each 20 patients), to receive preloading of intravenous fluid, as 
follows: Group 1 received  10 ml/kg of  low-MW tetrastarch in saline, group 
2 received 10 ml/kg medium-MW pentastarch in saline, group 3 had  10 
ml/kg of high-MW heta-starch in saline  and group 4 received 10 ml/kg 
Ringer lactate. It was concluded that  Preoperative fluid supplementation 
with LR, in a dose of 10 ml/kg, produced a lower incidence of  PONV 
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compared to colloid solutions. Tetrastarch could be a good alternative to 
LR, for prevention of PONV, due to its long lasting effect, up to 24 hours, 
postoperatively. In our study also we found that  Ringer Lactate (15 ml/kg) 
infusion pre-operatively reduced the incidence of  PONV at 2,6,12 hours. 
 
Gaurav Chauhan et al ( 2013)
52 
conducted a study  in 200 patients in 
the age group 20-40 years undergoing ambulatory gynaecological 
laparoscopic surgery.  This study concluded that intravenous hydration  
(30 ml/kg Compound Sodium Lactate) intra-operatively is a safe and 
effective means of preventing PONV. Our study results are similar to this 
study. The difference is amount of fluid administered is two times that of 
volume used in our study(15 ml/kg) and infusion was done intra-
operatively. 
Selcuk Yavuz et al (2014)
53
 studied the effects of preoperative 
intravenous hydration ( 15 ml /kg RL vs. 2 ml/kg RL ) on postoperative 
nausea and vomiting in high APFEL  scored patients undergoing 
laparoscopic cholecystectomy surgery. Hence the study stated that 
Preoperative hydration may be effective in high APFEL scored patients to 
prevent postoperative nausea. Our study results correlate with this study but 
those at high risk for PONV are excluded from our study.  
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Chohedri et al (2006)
54   This prospective randomized double-blind 
study was carried out in two hundred ambulatory surgical patients. This 
study concluded that preoperative high dose  hydration  can efficiently 
decrease the incidence of postoperative vomiting within the first 60 minutes 
in ambulatory surgeries . In our study we found that the incidence PONV is 
reduced at 2,6,12 hours 
Brandstrup et. al.
57
 compared a liberal vs. restrictive fluid strategy in 
172 patients undergoing colorectal surgery. Total IV fluids average 5.4 L for 
the liberal group and 2.7 L for the restrictive group. The restrictive regimen 
appeared to reduce the incidence of major and minor complications (ex. 
anastomotic leakage, pulmonary edema, pneumonia, and wound infection). 
This is in contrast to our study  and it once again confirms that type of 
surgery ( major vs. minor ) plays an important role in deciding the amount 
of fluid to be given. 
McCaul et al.
51
  found that large volume rehydration with a solution 
containing dextrose resulted in an increased requirement for opiate therapy 
in the PACU, compared with an equal volume of Ringer's lactate solution or 
no IV fluids. This increase in postoperative fentanyl requirement was likely 
caused by the presence of dextrose in the IV fluid, given that this did not 
occur with Ringer's lactate solution alone. 
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Effects on Pain 
In Group GL, the mean VAS scores at 2,6,12,24 hours 
(1.75±0.771,1,08± 0.688,.0.45± 0.610 ,0.20± 0.401)  were lesser when 
compared with Group GR(3.14±0.693,2.31±0.735,1.37±0.747,0.71±0.576) . 
There was a significant difference between the two groups. The p value is 
0.0005 at all intervals. Our study results correlate with the following study. 
Maharaj C.H. et al ( 2005
)48
  conducted  a randomized  study in 
eighty patients undergoing gynaecological laparoscopy who received either 
large (2 ml/kg/hour fasting)  or small(3 ml/kg) preoperatively. The 
incidence and severity of  pain, and need for supplement  analgesic therapy, 
were assessed by a blinded investigator at 0.5, 1, and 4 h postoperatively, 
and on the first and third postoperative days. Postoperative pain scores and 
supplemental analgesia were  decreased in large volume infusion group. The 
study concluded that preoperative correction of intravascular volume 
deficits effectively reduced postoperative pain.  
Effects on Discharge criteria 
         Discharge criteria was assessed using the Post Anaesthetic Discharge 
Scoring System. Out of a total score of 10, a score of ≥8 was considered fit 
for discharge. Group GL achieved the score of 8 earlier (at 6 hours ) 
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whereas patients in Group GR achieved it at 12 hours. The PADSS score 
was better in Group GL at all time intervals when compared with Group 
GR. 
Holte K et al
56
  in 2004 compared  intraoperative administration of 
40 ml/kg with 15 ml/kg LR in patients undergoing laparoscopic 
cholecystectomy. He concluded that intraoperative administration of 40 
mL/kg compared with 15 mL/kg LR improves postoperative organ functions 
and recovery and shortens hospital stay 
Gaurav Chauhan et al ( 2013)
52  concluded that intravenous 
hydration is a safe and effective means of preventing PONV and ensuring 
patient satisfaction at the time of discharge. The findings in our study agree 
with the above two studies.
 
EFFECTS ON GENERAL WELL-BEING    
General Well-being of the patients was recorded by asking the 
symptoms of thirst, headache, dizziness, drowsiness and fatigue.  
THIRST   
In Group GL, at 2 hours , 18 patients (35.3%) had thirst and in Group 
GR 39 patients had thirst (76.5%). At  6 hours , in Group GL,  
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14 patients( 27.5%) had thirst  and in group GR, 26 patients (51%) had a 
positive symptom which was statistically significant. No significant 
difference was achieved at 12 and 24 hours between the two groups.  
Yogendran .S et al
11
 in his study mentioned that the incidence of 
thirst was significantly lower in the high-infusion group (20 ml /Kg) hen 
compared with low infusion group (2 ml/kg) 
Chohedri et al
54
 showed in his study that preoperative high dose 
hydration  can efficiently decrease the incidence of postoperative thirst and 
vomiting within the first 60 minutes in ambulatory surgeries   
Holte K et al
56
 found that the incidence of thirst was decreased 
post—operatively in those received 40 ml/kg Ringer Lactate. 
There was no significant difference in the scores of headache, 
dizziness, drowsiness and  fatigue at 2,6,12 and 24 hours between the two 
groups. 
Post-operative Exercise capacity and mobilization was assessed by a 
validated TUG test at 12 and 24 hours. The mean duration of TUG test at 12 
hours in both the groups were 37.51seconds with SD of 8.561 (Group GL) 
and 40.16 with SD of 8.900 (Group GR). The mean duration of TUG test at 
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24 hours in both the groups were was 15.63 with SD  of 5.181  (Group GL) 
and 16.73 with SD of 4.418 (Group GR) which was not statistically 
significant.  
At 12 and 24 hours, bowel sound was present in all patients in both 
the groups. At 2 hours, none of the patients passed flatus and defecated in 
both the groups At 24 hours, almost 98% in both the groups passed flatus, 
22 patients in group GL ( 43.1%) and 11 patients in group GR ( 21.6%) 
defecated which was not statistically significant. 
This is in accordance with Holte Kathrine et al
40
 study in 2007  who 
compared the effects of “liberal”( (median 4250 ml, range 3150–5200 ml) 
versus “restrictive” (median 1740 ml, range 1100–2165 ml) intravascular 
fluid administration in knee arthroplasty on physiological recovery as the 
primary outcome variable. He found no differences in exercise capacity 
(TUG test), general well-being, headache, dizziness, drowsiness or fatigue 
either pre or postoperatively between the groups and also the length of 
postoperative ileus did not differ between the groups. 
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CHAPTER  12 
SUMMARY 
The incidence of Post–Operative Nausea and Vomiting (PONV)  is 
significantly  reduced in liberal fluid group  when compared to restrictive 
fluid group . 
The incidence of  Pain is significantly reduced in liberal fluid group 
when compared to restrictive fluid group . 
The patients who received liberal fluid achieved discharge criteria 
earlier than those who received restrictive fluid.  
The incidence of thirst is significantly reduced in liberal fluid group 
when compared to restrictive fluid group. 
No significant difference is found for headache, dizziness, 
drowsiness, fatigue, post-operative ileus, Post-operative Exercise capacity 
and mobilization between both the groups. 
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CHAPTER 13 
CONCLUSION 
             The mean PONV Scores and VAS Pain Scores were  lesser in those 
who received liberal fluid (15 ml/kg) preoperatively. These patients 
achieved discharge criteria earlier when compared with restrictive fluid 
group. 
             Preoperative hydration effectively reduced PONV in patients 
presenting for ambulatory surgery. Hence I conclude that liberal fluid 
therapy is an inexpensive and safe therapy for reducing post-operative 
nausea and vomiting. 
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 PROFORMA 
Name: Indication: STUDYNO: 
Age: Study Consent: IP NO:   
Weight: ASA: MASTER CHARTNO: 
Height: 
BMI: 
Airway: 
EXCLUSION CRITERIA:⃝ BMI > 30  ⃝ Smokers   ⃝History of 
Motion Sickness ⃝Unstable haemodynamics   ⃝Systemic Illness involving 
renal, cardiac, GIT and nervous system  ⃝ Diseases complicating 
pregnancy 
A     ASSESSMENT 
M 
P 
L 
E 
IV ACCESS  Site:                                                  Size: 
PRELOADING FLUID: RL                                          VOLUME: 
GA/ TIVA 
Preoxygenation: 
IV. 
GLYCOPYROLLATE 
IV. MIDAZOLAM 
0.02mg/kg 
IV. PENTAZOCINE 
0.5 mg/kg 
   
IV.KETAMINE DOSE TIME 
Bolus 1.5 mg/kg   
Top up 0.5 mg/kg   
 
MONITORS 
ECG  ⃝ 
ANIBP  ⃝ 
SpO2  ⃝ 
ETCO2 ⃝ 
Temp  ⃝ 
  TIME PR BP SaO2 ETCO2 IV Fluid 
Baseline       
5       
10       
15       
20       
25       
30       
35       
40       
45       
50       
55       
60       
       
 2  hours 6 hours 12 hours 24 hours 
Pain – VAS score     
Nausea/ Vomiting -  4 point scale     
Ileus – Bowel sounds ( YES/NO)     
Ileus – Passing Flatus ( YES/NO)     
Ileus - Defecation ( YES/NO)     
Exercise capacity and Mobilization – 
TUG test in secs 
    
General well-being -  Thirst 
YES =1, NO =0 
    
General well-being – Dizziness 
YES =1, NO =0 
    
General well-being – Headache 
YES =1, NO =0 
    
General well-being – Drowsiness 
YES =1, NO =0 
    
General well-being – Fatigue 
YES =1, NO =0 
    
Discharge Criteria 
PADSS 
    
  
 
 CONSENT FORM 
 
 
 
 MASTER CHART - I 
S.NO STUDY NO. STUDY 
DATE 
NAME AGE GENDER IP 
NO. 
WEIGHT HEIGHT BMI ASA GROUP DURATION OF SURGERY 
PULSE RATE SBP DBP MAP 
BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min 
1 1 01/03/17 Priya 25 F 16276 40 kgs 150 cms 17.77 PS I GL 15 mins 58 90 93 108 101 119 147 138 137 136 72 100 96 94 83 87 115 110 108 100 
2 1 05/03/17 Hepzibah 25 F 16525 52 kgs 155 cms 21.66 PS I GR 20 mins 81 82 86 84 98 110 120 142 144 132 70 82 86 90 86 83 94 104 108 101 
3 2 05/03/17 Saranya 23 F 16526 50 kgs 154 cms 21.09 PS I GR 20 mins 84 86 88 86 86 122 126 132 134 136 82 84 86 82 86 95 98 101 99 102 
4 3 05/03/17 Lavanya 28 F 16415 56 kgs 152 cms 24.24 PS I GL 20 mins 89 91 108 107 106 124 132 142 144 142 76 84 86 88 84 92 100 104 106 103 
5 1 07/03/17 Tamilselvi 30 F 16469 50 kgs 154 cms 22 PS I GL 15 mins 91 94 108 110 109 131 134 142 144 151 86 88 86 88 84 101 103 104 106 106 
6 2 07/03/17 Varalakshmi 25 F 16534 50 kgs 158 cms 20.8 PS I GR 20 mins 86 88 92 94 104 128 138 142 139 138 86 76 86 78 84 100 96 104 98 102 
7 1 08/03/17 Bagyalakshmi 26 F 16556 50 kgs 159 cms 20 PS I GR 15 mins 104 110 108 106 104 148 152 134 132 128 86 88 76 78 82 106 109 95 96 97 
8 2 08/03/17 Dhivya 21 F 16317 60 kgs 152 cms 26.66 PS I GR 20 mins 115 98 96 94 92 136 128 124 131 128 84 76 82 83 76 101 93 96 99 93 
9 3 08/03/17 Priya 23 F 16574 50 kgs 152 cms 21 PS I GL 20 mins 84 86 88 92 91 124 122 134 132 138 76 86 76 84 86 92 98 95 100 103 
10 1 09/03/17 Thasleema 24 F 16638 60 kgs 156 cms 24.69 PS I GL 20 mins 90 92 105 110 108 120 110 130 136 140 80 70 80 90 90 93 83 96 105 106 
11 2 09/03/17 Indumathi 22 F 16636 50 kgs 152 cms 21.73 PS I GL 20 mins 88 94 102 110 97 110 126 130 140 130 70 80 84 90 80 83 95 99 106 96 
12 1 15/3/2017 Nandhini 23 F 16745 40 kgs 156 cms 18 PS I GR 15 mins 68 81 99 98 96 130 143 156 152 152 80 82 94 86 82 96 102 114 108 105 
13 1 16/3/2017 Sathiyakala 32 F 17040 62 kgs 156 cms 27.5 PS I GL 15 mins 84 88 86 82 89 132 131 128 118 124 76 84 82 76 78 94 99 97 90 93 
14 2 16/3/2017 Faritha 27 F 16946 35 kgs 150 cms 16 PS I GL 20 mins 120 125 126 131 132 130 142 138 146 142 80 86 92 94 88 96 104 107 111 106 
15 3 16/3/2017 Mala 25 F 17039 50 kgs 154 cms 22 PS I GR 20 mins 77 81 82 88 90 120 128 134 132 136 70 84 76 84 86 83 98 95 100 102 
16 1 17/3/2017 Suriya 24 F 17019 55 kgs 154 cms 24.4 PS I GR 15 mins 76 90 90 70 78 118 114 113 128 124 77 78 82 84 86 89 90 92 98 98 
17 2 17/3/2017 Nandhini 22 F 16892 60 kgs 158 cms 24.09 PS I GR 15 mins 83 73 70 82 80 126 124 164 160 145 82 74 102 95 97 96 84 115 117 109 
18 3 17/3/2017 Subadradevi 30 F 16962 50 kgs 140 cms 25.5 PS I GR 20 mins 108 106 104 105 94 138 114 116 115 113 93 71 74 84 84 108 85 88 91 93 
19 4 17/3/2017 Tamil Elakiya 23 F 16897 58 kgs 150 cms 25.7 PS I GR 15 mins 80 89 98 98 105 141 163 169 157 145 93 110 117 111 101 109 126 131 123 113 
20 5 17/3/2017 Saranya Devi 26 F 16876 65 kgs 160 cms 25.3 PS I GR 15 mins 84 71 78 81 80 110 115 106 110 112 69 68 69 80 89 83 84 79 94 96 
21 6 17/3/2017 Vijaya 28 F 16767 55 kgs 153 cms 24.4 PS I GL 15 mins 86 115 118 116 108 124 142 146 138 132 86 86 96 76 84 98 104 112 96 100 
22 7 17/3/2017 Latha 26 F 16866 55 kgs 152 cms 24.4 PS I GR 20 mins 81 89 86 94 88 126 132 131 134 136 78 84 78 82 79 94 100 95 99 98 
23 8 17/3/2017 Sheelarani 26 F 16894 60 kgs 153 cms 26.6 PS I GR 20 mins 81 98 96 84 88 132 146 142 132 138 84 92 94 86 88 100 110 110 101 104 
24 1 19/3/2017 KanchanaAngel 28 F 16963 65 kgs 1.57 cms 29 PS I GR 20 mins 92 79 82 83 86 130 130 132 136 134 90 90 84 82 86 103 103 100 100 102 
25 2 19/3/2017 Lalitha 24 F 16896 49 kgs 1.46 cms 23 PS I GR 15 mins 83 86 87 77 85 133 136 142 144 137 89 88 92 102 103 103 104 108 116 114 
26 3 19/3/2017 Sivaranjani 24 F 17072 49 kgs 150 cms 21.7 PS I GR 20 mins 82 94 95 102 105 133 136 143 142 144 82 84 92 86 82 99 101 109 104 102 
27 4 19/3/2017 Meena 22 F 16887 75 kgs 162 cms 29.2 PS I GL 15 mins 82 84 93 91 102 107 131 139 138 134 74 93 96 92 89 85 105 110 107 104 
28 1 20/3/2017 Malathi 24 F 17122 58 kgs 164 cms 21.64 PS I GL 15 mins 76 95 107 110 111 129 135 150 145 143 72 90 107 93 89 91 105 121 110 107 
29 2 20/3/2017 Bagyalakshmi 24 F 16878 54 kgs 159 cms 21.6 PS I GL 15 mins 64 71 74 94 81 143 137 137 149 144 81 92 92 102 98 101 107 107 113 110 
30 3 20/3/2017 Regina 36 F 17117 42 kgs 154 cms 17.7 PS I GL 20 mins 102 105 108 113 114 132 145 154 136 144 90 101 106 98 98 104 116 122 111 110 
31 4 20/3/2017 Geetha 25 F 17144 40 kgs 150 cms 17.7 PS I GL 15 mins 84 93 108 113 118 126 136 151 145 141 84 97 105 100 98 96 106 118 114 110 
32 1 21/3/2017 Jancy Mary 25 F 17163 65 kgs 153 cms 28.8 PS I GL 15 mins 99 102 101 100 98 157 160 155 147 138 98 98 96 81 83 115 118 116 107 100 
33 2 21/3/2017 Akilandam 23 F 16923 70 kgs 154 cms 29.7 PS I GL 20 mins 74 81 78 88 89 111 118 140 146 134 67 82 100 101 92 78 90 111 113 101 
34 3 21/3/2017 Nagammal 31 F 17038 50 kgs 152 cms 22.22 PS I GL 20 mins 74 75 89 77 78 112 112 120 128 128 72 65 83 93 93 85 81 95 105 105 
35 4 21/3/2017 Poongodi 30 F 16963 50 kgs 158 cms 20.08 PS I GL 15 mins 90 81 78 70 77 110 94 120 134 131 72 66 84 94 95 85 75 96 107 107 
36 1 23/3/2017 Sowmiya 24 F 17333 60 kgs 158 cms 24.09 PS I GL 15 mins 81 91 85 83 91 116 105 116 114 115 75 69 71 78 78 89 81 86 90 91 
37 2 23/3/2017 Usha 28 F 17332 40 kgs 156 cms 16.46 PS II GL 15 mins 77 91 95 98 91 127 103 103 121 129 86 68 68 87 90 100 80 80 98 103 
38 3 23/3/2017 Saranya 29 F 17405 50 kgs 154 cms 21.09 PS I GL 20 mins 88 89 83 92 96 134 111 133 132 136 89 70 96 84 86 104 84 108 100 104 
39 4 23/3/2017 Shaira 24 F 17331 50 kgs 152 cms 21.64 PS I GR 20 mins 133 108 114 104 106 135 105 131 140 135 91 59 94 93 81 106 74 106 109 99 
40 5 23/3/2017 Sunitha 26 F 17248 50 kgs 160 cms 19.53 PS I GR 20 mins 83 96 86 96 96 120 140 138 130 137 76 96 86 88 90 92 110 103 102 105 
41 6 23/3/2017 Durga 27 F 17213 40 kgs 152 cms 17.39 PS I GR 15 mins 83 90 110 111 113 120 159 132 128 134 86 106 93 90 92 98 120 106 101 106 
42 7 23/3/2017 Nisha 27 F 17270 48 kgs 149 cms 21.62 PS I GR 15 mins 80 96 100 100 104 119 156 155 142 142 89 108 103 96 96 96 126 121 113 113 
43 1 26/3/2017 Sathya 28 F 17211 70 kgs 163 cms 26.41 PS I GL  20 mins 76 81 80 84 86 116 144 142 144 146 79 104 97 98 101 88 116 110 113 116 
44 2 26/3/2017 Divya 20 F 17398 45 kgs 152 cms 20 PS I GL 20 mins 92 94 105 106 104 128 132 158 155 147 91 97 104 96 86 101 107 120 118 116 
45 3 26/3/2017 Devi 31 F 17471 45 kgs 150 cms 20 PS I GR 20 mins 92 96 97 96 95 133 122 120 134 136 94 83 86 88 92 107 96 97 103 106 
46 4 26/3/2017 Suganya 25 F 17509 40 kgs 152 cms 17.31 PS I GL 15 mins 97 100 102 108 106 130 125 135 138 140 89 90 98 98 99 108 102 108 111 112 
47 1 27/3/2017 Malathy 26 F 17168 65 kgs 165 cms 25.3 PS II GR 15 mins 65 85 90 93 96 123 131 145 161 153 81 90 109 110 106 95 104 121 127 122 
48 2 27/3/2017 Kokila 23 F 17364 50 kgs 156 cms 22.22 PS II GL 15 mins 73 92 90 93 89 145 152 145 160 146 97 106 104 110 104 111 120 117 127 116 
49 1 28/3/2017 Shakira Banu 22 F 17359 55 kgs 154 cms 23.2 PS II GR 20 mins 87 109 112 116 114 138 168 164 158 154 87 90 86 78 68 104 116 112 104 96 
50 1 31/3/2017 Datchayini 22 F 17566 50 kgs 154 cms 21.09 PS II GL 20 mins 88 92 90 92 93 110 120 152 136 130 70 81 95 80 84 83 92 115 100 98 
 S.NO STUDY NO. STUDY 
DATE 
NAME AGE GENDER IP 
NO. 
WEIGHT HEIGHT BMI ASA GROUP DURATION OF SURGERY 
PULSE RATE SBP DBP MAP 
BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min BASELINE 5 min 10 min 15 min 20 min 
51 2 31/3/2017 Sowmiya 24 F 17561 50 kgs 164 cms 19.53 PS I GL 20 mins 60 85 96 99 94 120 138 153 146 135 76 96 109 104 95 91 110 124 118 108 
52 3 31/3/2017 Nandhini 23 F 17506 45 kgs 156 cms 20 PS II GL 20 mins 89 92 109 103 99 110 111 134 124 119 71 69 90 83 80 84 83 105 97 92 
53 4 31 /3/2017 Aruna rani 31 F 17032 55 kgs 160 cms 21.48 PS II GL 15 mins 92 94 107 105 110 118 120 124 140 145 72 82 90 90 93 84 93 99 101 106 
54 5 31 /3/2017 Sharmila 25 F 17617 50 kgs 158 cms 20.08 PS II GL 20 mins 88 92 92 94 95 113 121 131 139 155 75 88 82 90 103 88 99 82 104 119 
55 6 31 /3/2016 Abirami 21 F 17605 48 kgs 160 cms 18.75 PS I GR 15 mins 98 97 112 115 115 108 136 148 149 140 86 90 92 94 92 93 105 111 112 108 
56 1 04-01-17 Deepa 27 F 979 50 kgs 155 cms 20.83 PS I GR 20 mins 102 104 108 108 109 124 128 136 121 128 76 82 92 76 86 92 97 106 91 100 
57 2 04-01-17 Sudha 24 F 1025 62 kgs 170 cms 21.45 PS I GL 20 mins 91 109 119 109 108 121 132 142 137 136 78 86 104 94 84 92 101 114 106 101 
58 3 04-01-17 Vasantha 32 F 1043 47 kgs 146 cms 22.06 PS I GR 20 mins 89 109 105 95 96 130 144 154 157 148 83 95 116 108 98 99 111 128 124 114 
59 4 04-01-17 Sangeetha 23 F 1104 50 kgs 154 cms 21.09 PS II GL 15 mins 86 119 112 88 86 124 101 116 112 118 78 65 77 71 64 90 77 90 85 82 
60 5 04-01-17 Priya 23 F 1344 52 kgs 152 cms 21.64 PS  II GL 15 mins 89 105 70 74 78 115 123 107 118 132 72 89 72 85 74 86 89 72 85 93 
61 1 04-03-17 Shama 26 F 1174 45 kgs 150 cms 20 PS II GL 20 mins 113 93 103 110 112 112 95 109 118 116 71 48 60 72 74 85 64 76 82 88 
62 2 04-03-17 Rani 27 F 1172 40 kgs 150 cms 17.77 PS II GL 20 mins 84 88 102 101 98 118 108 98 102 104 78 86 64 92 86 91 93 75 95 92 
63 3 04-03-17 Suguna 24 F 17686 60 kgs 156 cms 26.66 PS II GR 15 mins 92 98 106 104 99 100 110 136 139 128 66 70 90 92 86 75 83 105 106 100 
64 4 04-03-17 Karpagam 28 F 17698 66  kgs 150 cms 29.33 PS II GR 15 mins 90 98 102 98 100 150 167 172 151 148 89 100 98 100 98 109 122 122 117 114 
65 5 04-03-17 Saranya 24 F 17630 48 kgs 155 cms 20 PS II GR 20 mins 82 106 111 106 101 106 128 127 129 119 70 84 86 90 82 85 99 99 103 95 
66 6 04-03-17 Samsath 29 F 17655 54 kgs 152 cms 23.37 PS I GL 20 mins 83 100 97 92 96 124 133 135 135 129 72 89 91 90 84 88 102 103 102 99 
67 7 04-03-17 Esther 24 F 17711 55 kgs 151 cms 24.44 PS I GL 15 mins 88 94 96 92 94 140 148 149 156 141 76 84 71 77 76 97 105 101 107 98 
68 1 04-07-17 Maharani 28 F 1231 55 kgs 156 cms 22.63 PS I GL 15 mins 83 103 104 112 117 112 138 138 129 136 75 104 100 93 92 84 113 110 102 101 
69 1 04-09-17 Angammal 24 F 1394 45 kgs 151 cms 19.73 PS I GR 15 mins 119 129 122 130 122 123 144 140 134 133 70 94 92 85 86 88 111 108 101 101 
70 2 04-09-17 Nasima Begum 21 F 1379 50 kgs 152 cms 21.64 PS I GR 20 mins 92 88 91 99 90 113 122 146 128 123 72 84 98 86 87 83 96 118 99 97 
71 3 04-09-17 Shahin Fathima 34 F 1413 65 kgs 154 cms 27.42 PS II GR 20 mins 116 129 118 99 96 125 114 126 136 125 78 74 85 92 84 94 87 99 107 97 
72 1 04-11-17 Dillirani 26 F 1476 62 kgs 155 cms 25.83 PS II GR 15 mins 101 127 136 124 119 127 162 163 148 142 86 104 103 91 90 100 123 123 113 107 
73 1 04-12-17 Vinitha 21 F 1554 55 kgs 152 cms 23.8 PS I GL 20 mins 91 102 92 110 101 139 120 145 135 151 83 61 89 79 85 102 81 108 98 107 
74 2 04-12-17 Mariyam Beevi 26 F 1550 50 kgs 148 cms 22.83 PS II GL 20 mins 96 97 100 100 98 112 119 126 148 135 51 71 80 101 79 71 87 95 117 98 
75 1 16/4/2017 Deepa 35 F 1701 65 kgs 154 cms 27.42 PS II GR 15 mins 84 88 95 82 81 114 90 101 105 114 73 58 62 65 61 87 69 76 78 79 
76 2 16/4/2017 Sumathy 23 F 1621 60 kgs 152 cms 25.97 PS I GL 15 mins 101 87 73 78 89 140 110 126 124 148 80 56 65 74 91 100 74 85 91 110 
77 1 17/4/2017 Soniya 26 F 1695 52 kgs 153 cms 22.22 PS I GR 20 mins 84 89 90 90 88 133 132 145 137 136 85 85 100 93 92 102 101 115 108 106 
78 1 18/4/2017 Manjula 28 F 1728 60 kgs 158 cms 24.09 PS I GL 15 mins 82 115 104 99 104 128 146 143 146 142 86 102 93 92 93 100 117 110 110 109 
79 1 25/4/2017 Yuganya 24 F 1953 40 kgs 164 cms 14.92 PS II GR 15 mins 88 113 118 122 118 127 144 137 138 129 84 101 98 94 88 98 115 111 109 102 
80 1 07-03-17 Arokiya Mari 32 F 8066 52 kgs 154 cms 21.94 PS I GL 15 mins 84 86 98 102 101 128 134 142 138 144 86 92 84 86 100 102 108 108 102 105 
81 2 07-03-17 Maheshwari 32 F 8009 54 kgs 152 cms 23.37 PS II GR 20 mins 88 99 104 106 108 118 124 132 142 144 76 82 86 92 94 90 96 101 108 110 
82 3 07-03-17 Nandhini 28 F 8124 52 kgs 155 cms 21.66 PS I GL 20 mins 74 88 96 104 110 112 128 136 144 142 72 86 88 92 88 85 100 104 109 106 
83 1 07-05-17 Mariayammal 25 F 8300 52 kgs 156 cms 21.39 PS II GL 15 mins 88 101 110 112 108 124 136 138 142 144 82 88 92 86 88 96 104 107 104 106 
84 2 07-05-17 Rajeshwari 23 F 8112 49 kgs 154 cms 20.67 PS II GR 20 mins 88 98 102 104 110 132 134 142 144 142 86 88 94 104 96 101 103 110 117 111 
85 3 07-05-17 Thirumathy 26 F 8098 50 kgs 156 cms 20.57 PS I GR 20 mins 76 84 89 101 110 114 126 138 142 144 78 82 84 86 94 90 94 102 104 110 
86 1 07-06-17 Shyamala 27 F 8360 56 kgs 148 cms 25.57 PS II GL 15 mins 82 92 98 108 104 126 134 142 141 138 84 86 88 86 84 98 102 106 104 102 
87 2 07-06-17 Malini 21 F 8296 55 kgs 158 cms 22.08 PS I GL 20 mins 88 89 92 110 112 122 129 134 138 142 84 88 92 96 96 96 101 106 110 111 
88 1 07-08-17 Prema 23 F 8390 40 kgs 154 cms 16.87 PS II GR 20 mins 111 115 116 118 112 135 132 130 144 142 83 85 86 88 86 100 101 101 115 104 
89 2 07-08-17 Kalpana 27 F 8348 55 kgs 164 cms 20.52 PS I GL 20 mins 99 115 112 116 118 115 116 130 136 134 78 74 93 86 82 88 86 103 102 99 
90 1 07-10-17 Manimegalai 29 F 8527 65 kgs 151 cms 28.5 PS I GL 15 mins 77 112 105 106 104 125 159 140 137 138 75 103 91 82 86 94 122 107 106 103 
91 2 07-10-17 Saina 26 F 8424 50 kgs 144 cms 25.51 PS I GR 15 mins 84 94 109 111 112 106 118 157 161 148 71 82 114 113 110 83 93 128 126 122 
92 3 07-10-17 Dhanalakshmi 29 F 8315 57 kgs 144 cms 27.53 PS I GR 20 mins 77 81 95 91 92 125 135 150 159 162 74 90 102 98 107 87 101 116 112 123 
93 1 07-11-17 Bharathy 24 F 8472 40 kgs 152 cms 17.31 PS I GR 20 mins 71 86 92 98 101 118 128 136 138 134 78 86 92 88 82 91 100 106 104 99 
94 2 07-11-17 Janarthana 25 F 8290 57 kgs 150 cms 25.33 PS II GR 15 mins 82 88 92 96 102 131 134 138 141 142 76 86 88 89 88 94 102 104 106 106 
95 3 07-11-17 Tamilselvi 20 F 8553 48 kgs 155 cms 20 PS II GR 20 mins 76 78 84 88 92 122 129 134 136 142 72 76 82 89 92 88 93 99 104 108 
96 1 17/7/2017 Uma 30 F 8774 51 kgs 150 cms 22.66 PS II GR 15 mins 82 98 100 94 91 128 121 151 156 136 81 81 101 105 94 97 94 117 122 108 
97 2 17/7/2017 Muthazhagi 23 F 8770 65 kgs 150 cms 28.88 PS II GR 20 mins 82 95 104 111 110 137 146 143 144 142 82 99 94 89 86 101 116 103 103 113 
98 3 17/7/2017 Faritha 23 F 8757 62 kgs 161 cms 23.93 PS II GR 20 mins 77 112 101 99 98 114 145 143 138 142 76 102 99 88 86 89 116 114 104 104 
99 4 17/7/2017 Jayanthi 26 F 8706 62 kgs 160 cms 24.21 PS II GL 15 mins 77 99 102 104 106 117 147 139 137 136 69 90 85 72 74 85 109 103 92 94 
100 5 17/7/2017 Ashwini 25 F 8781 59 kgs 158 cms 23.69 PS II GL 20 mins 83 88 110 125 121 121 125 131 137 139 73 84 88 89 84 87 95 98 104 102 
101 6 17/7/2017 Sumathy 24 F 8776 52 kgs 150 cms 23.11 PS II GR 15 mins 86 102 99 97 102 107 115 143 128 130 71 80 103 94 94 83 92 116 105 106 
102 7 17/7/2017 Praveena 21 F 8755 42 kgs 144 cms 20.28 PS II GR 20 mins 71 80 96 105 104 106 123 131 124 121 65 88 91 81 82 77 94 101 91 95 
 
 MASTER CHART – II 
S.N
O 
STUD
Y 
 NO. 
STUDY 
DATE 
NAME 
AG
E 
      PAIN - VAS 
SCORE 
4 Point PONV 
SCALE                ILEUS - BOWEL 
SOUNDS 
ILEUS - PASSING 
FLATUS 
                  ILEUS - 
DEFECATION 
TUG 
TEST 
GENERAL   WELL-BEING    -  
THIRST 
GENERAL WELL-BEING -  
DIZZINESS 
GENERAL WELL-BEING -  
HEADACHE 
GENERAL WELL-BEING -  
DROWSINESS 
GENERAL WELL-BEING -  
FATIGUE 
DISCHARGE  CRITERIA - 
PADSS 
2 h 6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  
1  1 
01/03/17 
Priya 
25 
3 3 2 1 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
35 
sec 
30 
sec 1 1  
1 
0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 7 8 10 10 
2  1 
05/03/17 
Hepzibah 
25 
4 3 2 1 2 1 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
40 
sec 
20 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 6 8 9 10 
3  2 
05/03/17 
Saranya 
23 
5 4 1 1 2 1 1 1 Yes Yes Yes Yes No No Yes Yes No No No No 
35 
sec 
15 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 10 10 
4  3 
05/03/17 
Lavanya 
28 
2 0 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
30 
sec 
15 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 9 9 10 
5  1 
07/03/17 
Tamilselvi 
30 
2 1 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
36 
sec 
30 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
6  2 
07/03/17 
Varalakshmi 
25 
2 1 1 0 2 1 1 0 Yes Yes Yes Yes No No Yes Yes No No Yes Yes 
40 
sec 
20 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 9 
7  1 08/03/17 
Bagyalaksh
mi 26 
3 2 1 0 2 1 1 0 Yes Yes Yes Yes No Yes Yes Yes No No No No 
35 
sec 
15 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 10 
8  2 
08/03/17 
Dhivya 
21 
3 2 2 0 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
25 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 10 
9  3 
08/03/17 
Priya 
23 
2 1 1 0 1 1 0 0 Yes Yes Yes Yes No Yes Yes Yes No No No No 
30 
sec 
15 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
10 1 
09/03/17 
Thasleema 
24 
2 1 1 0 0 0 0 0 Yes Yes Yes Yes No Yes Yes Yes No No No No 
35 
sec 
15 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 9 9 10 
11 2 
09/03/17 
Indumathi 
22 
2 0 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
32 
sec 
15 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
12 1 15/3/201
7 
Nandhini 
23 
3 1 1 1 2 1 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
38 
sec 
30 
sec 1 0  0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 6 7 9 10 
13 1 16/3/201
7 
Sathiyakala 
32 
3 2 1 1 0 0 0 0 Yes Yes Yes Yes No Yes Yes Yes No No No No 
30 
sec 
15 
sec 1 1  0 0 0 0 0 0 0 0 1 0 6 0 0 0 0 0 0 0 7 8 9 10 
14 2 16/3/201
7 
Faritha 
27 
2 1 1 1 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
35 
sec 
15 
sec 1 1  0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 10 10 
15 3 16/3/201
7 
Mala 
25 
2 2 0 0 1 1 1 0 Yes Yes Yes Yes No No No No No No No No 
35 
sec 
20 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 10 10 
16 1 17/3/201
7 
Suriya 
24 
3 2 2 1 2 2 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
38 
sec 
15 
sec 1 1  1 1 1 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 6 7 10 10 
17 2 17/3/201
7 
Nandhini 
22 
3 2 1 0 2 2 0 0 Yes Yes Yes Yes No No No Yes No No No No 
40 
sec 
15 
sec 1 1  1 1 1 1 0 0 0 0 0 0 1 1 0 0 0 1 0 0 6 7 10 10 
18 3 17/3/201
7 
Subadradevi 
30 
3 2 1 1 1 2 1 0 No Yes Yes Yes No No Yes Yes No No No No 
40 
sec 
16 
sec 1 1  1 1 0 1 0 0 0 0 0 0 0 1 0 0 1 1 0 0 6 7 10 10 
19 4 17/3/201
7 
Tamil 
Elakiya 23 
2 2 2 1 2 2 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
60 
sec 
25 
sec 1 1  1 1 0 1 0 0 0 0 0 0 1 1 0 0 0 1 0 0 5 7 10 10 
20 5 17/3/201
7 
Saranya 
Devi 26 
3 2 1 1 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No Yes 
62 
sec 
20 
sec 1 1  1 1 1 1 0 0 0 0 0 0 1 1 0 0 1 1 0 0 6 7 10 10 
21 6 17/3/201
7 
Vijaya 
28 
2 1 0 0 1 0 0 1 Yes Yes Yes Yes No No Yes Yes No No No No 
65 
sec 
15 
sec 1 1  1 1 1 1 0 0 0 0 0 0 1 1 0 0 0 1 0 0 7 8 10 10 
22 7 17/3/201
7 
Latha 
26 
4 3 1 1 1 2 1 0 No No Yes Yes No No Yes Yes No No No Yes 
55 
sec 
20 
sec 1 1  1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 1 0 0 6 7 10 10 
 S.N
O 
STUD
Y 
 NO. 
STUDY 
DATE 
NAME 
AG
E 
      PAIN - VAS 
SCORE 
4 Point PONV 
SCALE                ILEUS - BOWEL 
SOUNDS 
ILEUS - PASSING 
FLATUS 
                  ILEUS - 
DEFECATION 
TUG 
TEST 
GENERAL   WELL-BEING    -  
THIRST 
GENERAL WELL-BEING -  
DIZZINESS 
GENERAL WELL-BEING -  
HEADACHE 
GENERAL WELL-BEING -  
DROWSINESS 
GENERAL WELL-BEING -  
FATIGUE 
DISCHARGE  CRITERIA - 
PADSS 
2 h 6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  
23  8 17/3/201
7 
Sheelarani 
26 
3 3 2 0 2 2 1 0 No No Yes Yes No No Yes Yes No No No No 
50 
sec 
15 
sec 1 1  0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 1 0 0 6 6 10 10 
24 1 19/3/201
7 
KanchanaAn
gel 28 
3 2 1 0 1 1 0 1 Yes Yes Yes Yes No No Yes Yes No No Yes Yes 
60 
sec 
20 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 10 
25 2 19/3/201
7 
Lalitha 
24 
3 2 1 0 1 1 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
49 
sec 
16 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 10 10 
26 3 19/3/201
7 
Sivaranjani 
24 
4 2 1 0 1 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
48 
sec 
12 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 10 
27 4 19/3/201
7 
Meena 
22 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
35 
sec 
10  
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
28 1 20/3/201
7 
Malathi 
24 
1 0 0 0 1 0 0 0 No Yes Yes Yes No No No Yes No No No Yes 
48 
sec 
14 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 9 10 
29 2 20/3/201
7 
Bagyalaksh
mi 24 
1 1 1 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
42 
sec 
12 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 7 9 10 10 
30 3 20/3/201
7 
Regina 
36 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
36 
sec 
14 
sec 0 0  0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 6 8 10 10 
31 4 20/3/201
7 
Geetha 
25 
2 1 0 0 0 0 0 0 No Yes Yes Yes No No Yes Yes No No No Yes 
38 
sec 
16 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 9 10 10 
32 1 21/3/201
7 
Jancy Mary 
25 
1 1 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
29 
sec 
14 
sec 1 1  0 0 1 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 7 8 8 10 
33 2 21/3/201
7 
Akilandam 
23 
2 1 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
48 
sec 
10 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
34 3 21/3/201
7 
Nagammal 
31 
2 1 0 0 1 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
35 
sec 
10 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 10 
35 4 21/3/201
7 
Poongodi 
30 
1 0 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
40 
sec 
12 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 8 10 
36 1 23/3/201
7 
Sowmiya 
24 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
45 
sec 
18 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 9 10 
37 2 23/3/201
7 
Usha 
28 
0 1 0 1 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
50 
sec 
20 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 10 10 
38 3 23/3/201
7 
Saranya 
29 
2 1 1 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
48 
sec 
18 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 10 10 
39 4 23/3/201
7 
Shaira 
24 
4 3 1 0 2 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
42 
sec 
18 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
40 5 23/3/201
7 
Sunitha 
26 
3 2 1 0 1 1 1 0 No Yes Yes Yes No No Yes Yes No No No Yes 
45 
sec 
16 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 6 8 10 
41 6 23/3/201
7 
Durga 
27 
3 2 1 1 2 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
46 
sec 
20 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 7 9 10 
42 7 23/3/201
7 
Nisha 
27 
3 2 1 1 1 1 1 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
54 
sec 
22 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
43 1 26/3/201
7 
Sathya 
28 
1 0 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
60 
sec 
30 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
44 2 26/3/201
7 
Divya 
20 
2 1 1 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
41 
sec 
14 
sec 1 0  0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
45 3 26/3/201
7 
Devi 
31 
3 3 2 2 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
48 
sec 
15 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 6 7 8 10 
46 4 26/3/201
7 
Suganya 
25 
2 2 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
52 
sec 
19 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 10 10 
 S.N
O 
STUD
Y 
 NO. 
STUDY 
DATE 
NAME 
AG
E 
      PAIN - VAS 
SCORE 
4 Point PONV 
SCALE                ILEUS - BOWEL 
SOUNDS 
ILEUS - PASSING 
FLATUS 
                  ILEUS - 
DEFECATION 
TUG 
TEST 
GENERAL   WELL-BEING    -  
THIRST 
GENERAL WELL-BEING -  
DIZZINESS 
GENERAL WELL-BEING -  
HEADACHE 
GENERAL WELL-BEING -  
DROWSINESS 
GENERAL WELL-BEING -  
FATIGUE 
DISCHARGE  CRITERIA - 
PADSS 
2 h 6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  
47  1 27/3/201
7 
Malathy 
26 
4 2 1 0 2 1 1 1 Yes Yes Yes Yes No No No Yes No No No Yes 
60 
sec 
22 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 8 10 
48 2 27/3/201
7 
Kokila 
23 
2 1 1 0 1 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
49 
sec 
20 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
49 1 28/3/201
7 
Shakira 
Banu 22 
3 4 4 2 1 1 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
60 
sec 
32 
sec 1 1  1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
50 1 31/3/201
7 
Datchayini 
22 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
48 
sec 
34 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 10 10 
51 2 31/3/201
7 
Sowmiya 
24 
4 2 2 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
44 
sec 
14 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 8 10 
52 3 31/3/201
7 
Nandhini 
23 
4 3 2 1 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
54 
sec 
19 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 8 10 
53 4 
31 
/3/2017  
Aruna rani 
31 
2 2 1 1 0 0 1 0 Yes Yes Yes Yes No No No Yes No No No Yes 
35 
sec 
15 
sec 0 0  1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 7 8 9 10 
54 5 31 
/3/2017  
Sharmila 
25 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
32 
sec 
12 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 8 9 10 
55 6 31 
/3/2016 
Abirami 
21 
3 3 2 1 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No Yes 
35 
sec 
15 
sec 1 0  0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 7 8 9 10 
56 1 04-01-
17 
Deepa 
27 
3 3 2 1 3 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
30 
sec 
12 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
57 2 04-01-
17 
Sudha 
24 
2 1 1 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
35 
sec 
15 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 10 10 
58 3 04-01-
17 
Vasantha 
32 
4 2 1 1 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
32 
sec 
16 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 8 10 
59 4 04-01-
17 
Sangeetha 
23 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
32 
sec 
14 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
60 5 04-01-
17 
Priya 
23 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
31 
sec 
16 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
61 1 04-03-
17 
Shama 
26 
2 1 1 1 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
30 
sec 
15 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
62 2 04-03-
17 
Rani 
27 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No No No No No No 
32 
sec 
14 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
63 3 04-03-
17 
Suguna 
24 
4 4 3 1 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
31 
sec 
18 
sec 1 1  0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 8 9 10 
64 4 04-03-
17 
Karpagam 
28 
4 4 3 2 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
38 
sec 
18 
sec 1 1  1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
65  5 04-03-
17 
Saranya 
24 
3 3 1 1 2 2 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
16 
sec 1 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 6 7 7 9 
66  6 04-03-
17 
Samsath 
29 
1 2 1 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
32 
sec 
13 
sec 0 1  0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 9 10 
67 7 04-03-
17 
Esther 
24 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
31 
sec 
14 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
68 1 04-07-
17 
Maharani 
28 
2 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
31 
sec 
15 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 8 9 10 
69 1 04-09-
17 
Angammal 
24 
3 2 2 1 1 1 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
34 
sec 
15 
sec 1 1  1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
70 2 04-09-
17 
Nasima 
Begum 21 
3 3 2 1 1 1 0 0 No No Yes Yes No No No Yes No No No No 
40 
sec 
18 
sec 0 1  1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 6 7 8 10 
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      PAIN - VAS 
SCORE 
4 Point PONV 
SCALE                ILEUS - BOWEL 
SOUNDS 
ILEUS - PASSING 
FLATUS 
                  ILEUS - 
DEFECATION 
TUG 
TEST 
GENERAL   WELL-BEING    -  
THIRST 
GENERAL WELL-BEING -  
DIZZINESS 
GENERAL WELL-BEING -  
HEADACHE 
GENERAL WELL-BEING -  
DROWSINESS 
GENERAL WELL-BEING -  
FATIGUE 
DISCHARGE  CRITERIA - 
PADSS 
2 h 6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  
71  3 04-09-
17 
Shahin 
Fathima 34 
3 2 2 1 1 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
35 
sec 
15 
sec 1 1  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
72  1 04-11-
17 
Dillirani 
26 
2 2 1 1 3 1 0 1 Yes Yes Yes Yes No No No Yes No No No No 
38 
sec 
16 
sec 1 1  0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
73  1 04-12-
17 
Vinitha 
21 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
35 
sec 
15 
sec 0 0  1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 8 8 9 10 
74 2 04-12-
17 
Mariyam 
Beevi 26 
2 1 1 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
32 
sec 
12 
sec 0 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 9 10 10 
75 1 16/4/201
7 
Deepa 
35 
3 3 1 1 2 1 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
32 
sec 
12 
sec 1 0  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
76  2 16/4/201
7 
Sumathy 
23 
2 1 1 1 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
30 
sec 
10 
sec 0 0  1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 8 9 9 10 
77 1 17/4/201
7 
Soniya 
26 
3 2 2 1 1 1 1 1 Yes Yes Yes Yes No No Yes Yes No No No No 
30 
sec 
12 
sec 1 0  0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 10 
78 1 18/4/201
7 
Manjula 
28 
1 0 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
31 
sec 
11 
sec 0 0  0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 9 9 10 
79 1 25/4/201
7 
Yuganya 
24 
3 2 1 0 1 2 0 0 Yes Yes Yes Yes No No No Yes No No No No 
32 
sec 
12 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 7 8 9 
80  1 07-03-
17 
Arokiya 
Mari 32 
1 0 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
30 
sec 
10 
sec 0 1  0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 8 9 10 
81 2 07-03-
17 
Maheshwari 
32 
3 2 1 1 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
34 
sec 
12 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
82  3 07-03-
17 
Nandhini 
28 
2 1 1 0 0 1 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
29 
sec 
13 
sec 1 0  0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
83 1 07-05-
17 
Mariayamma
l 25 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No Yes 
32 
sec 
14 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
84 2 07-05-
17 
Rajeshwari 
23 
3 3 2 1 0 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
35 
sec 
14 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
85  3 07-05-
17 
Thirumathy 
26 
2 2 1 1 2 1 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
36 
sec 
12 
sec 0 0  0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
86  1 07-06-
17 
Shyamala 
27 
1 1 0 0 1 1 0 0 Yes Yes Yes Yes No No No Yes No No No No 
30 
sec 
12 
sec 0 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
87 2 07-06-
17 
Malini 
21 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
38 
sec 
14 
sec 0 1  0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 7 9 9 10 
88 1 07-08-
17 
Prema 
23 
3 2 1 1 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
15 
sec 0 1  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
89  2 07-08-
17 
Kalpana 
27 
1 1 0 0 1 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No No 
35 
sec 
16 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
90 1 07-10-
17 
Manimegalai 
29 
1 1 0 0 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
37 
sec 
18 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
91 2 07-10-
17 
Saina 
26 
3 2 1 1 2 2 1 0 Yes Yes Yes Yes No No Yes Yes No No No No 
36 
sec 
16 
sec 1 0  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
92  3 07-10-
17 
Dhanalaksh
mi 29 
3 2 2 1 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
14 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
93  1 07-11-
17 
Bharathy 
24 
3 2 1 1 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No Yes 
31 
sec 
16 
sec 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 10 
94 2 07-11-
17 
Janarthana 
25 
3 2 2 1 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
15 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 10 
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SCORE 
4 Point PONV 
SCALE                ILEUS - BOWEL 
SOUNDS 
ILEUS - PASSING 
FLATUS 
                  ILEUS - 
DEFECATION 
TUG 
TEST 
GENERAL   WELL-BEING    -  
THIRST 
GENERAL WELL-BEING -  
DIZZINESS 
GENERAL WELL-BEING -  
HEADACHE 
GENERAL WELL-BEING -  
DROWSINESS 
GENERAL WELL-BEING -  
FATIGUE 
DISCHARGE  CRITERIA - 
PADSS 
2 h 6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  2 h  6 h  12 h  24 h  
95  3 07-11-
17 
Tamilselvi 
20 
2 2 1 0 1 2 1 0 Yes Yes Yes Yes No No No Yes No No No No 
36 
sec 
16 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 9 
96  1 17/7/201
7 
Uma 
30 
4 2 1 0 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
35 
sec 
14 
sec 0 0  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 7 9 9 
97  2 17/7/201
7 
Muthazhagi 
23 
4 1 0 0 1 0 1 0 Yes Yes Yes Yes No No No Yes No No No No 
33 
sec 
12 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 8 9 
98  3 17/7/201
7 
Faritha 
23 
2 1 0 0 1 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
34 
sec 
14 
sec 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 9 
99  4 17/7/201
7 
Jayanthi 
26 
3 3 1 1 0 0 0 0 Yes Yes Yes Yes No No Yes Yes No No No Yes 
32 
sec 
14 
sec 0 0  0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 8 8 9 10 
100 5 17/7/201
7 
Ashwini 
25 
2 1 1 1 0 0 0 0 Yes Yes Yes Yes No No No Yes No No No No 
31 
sec 
12 
sec 0 1  0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 7 8 9 10 
101 6 17/7/201
7 
Sumathy 
24 
5 3 1 1 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No No 
38 
sec 
11 
sec 0 0  0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 9 10 
102 7 17/7/201
7 
Praveena 
21 
3 2 1 0 2 1 1 0 Yes Yes Yes Yes No No No Yes No No No Yes 
33 
sec 
13 
sec 0 0  1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 7 7 9 10 
 
